STAT6 inhibitors and methods of use thereof
STAT6 inhibitors targeting IL-4 and IL-13 signaling offer a therapeutic solution for allergic and inflammatory diseases, addressing the lack of effective treatments for atopic dermatitis, asthma, and COPD.
Patent Information
- Application Number
- PCT/US2026/028175
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-12-19
- Filing Date
- 2026-05-14
- Publication Date
- 2026-11-19
AI Technical Summary
There are no approved STAT6 inhibitors for the treatment of allergic and inflammatory diseases such as atopic dermatitis, asthma, and chronic obstructive pulmonary disease, highlighting a significant unmet medical need.
Development of compounds that act as STAT6 inhibitors, modulating IL-4 and IL-13 signaling, to treat diseases associated with these cytokines.
The compounds effectively inhibit STAT6 activity, providing a therapeutic approach for conditions like atopic dermatitis, asthma, and COPD by modulating IL-4 and IL-13 signaling.
Smart Images

Figure US2026028175_19112026_PF_FP_ABST
Abstract
Description
WSGR Docket No. 70877-703.601STAT6 INHIBITORS AND METHODS OF USE THEREOFABSTRACT OF THE DISCLOSURE
[0001] This application claims the benefit of US Provisional Application Nos. 63 / 806,179, filed May 15, 2025; 63 / 843,628, filed July 14, 2025; and 63 / 945,170, filed December 19, 2025, each of which is incorporated by reference herein in its entirety.BACKGROUND
[0002] Signal Transducer and Activator of Transcription 6 (STAT6) may be primarily stimulated by interleukin 4 (IL-4) or interleukin 13 (IL-13), and may act as a T-helper type 2 (Th2)-inducing factor. STAT6 may be implicated in the pathogenesis of various allergic and inflammatory diseases, including atopic dermatitis, asthma, and chronic obstructive pulmonary disease (COPD). Upon cytokine receptor activation, STAT6 is phosphorylated on a specific tyrosine residue (Tyr641 in humans) by Janus kinases (JAKs). This phosphorylation event enables STAT6 to form homodimers or heterodimers (e.g., with STAT2) via reciprocal phosphotyrosine-Src Homology 2 (SH2) domain interactions. These activated STAT6 dimers then translocate to the nucleus, bind to specific DNA sequences, and modulate the transcription of target genes involved in inflammatory and immune responses. However, while STAT6 has been implicated in various conditions, to date there are no approved STAT6 inhibitors for treatment of said conditions. A large unmet medical need still exists for the treatment of these diseases, and new agents for the treatment of the above-mentioned diseases are needed.SUMMARY
[0003] Disclosed herein are compounds, or a pharmaceutically acceptable salt or stereoisomer thereof, that are STAT6 inhibitors and methods of use thereof. The STAT6 inhibitors may be useful in modulating interleukin 4 (IL-4) or interleukin 13 (IL- 13), or treating disease associated with IL-4 or IL-13.
[0004] In some embodiments, provided herein are compounds of Formula (I), or a pharmaceutically acceptable salt, or stereoisomer thereof:Formula (I),wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;WSGR Docket No. 70877-703.601G3is N, NRN3, CRG3, or C(RG3)2;each of RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, - NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci- Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2- Cealkynyl, G-Gscycloalkyl, 4-15 membered heterocycloalkyl, C-C^ar l. or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG2or RG3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RG1is hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, - NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F;or two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; orone of RN1, RN2, and RN3and one of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, C1-C3aminoalkyl, C2-C4alkenyl, C2-C4alkynyl, C1-C3heteroalkyl, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or one R2is takenWSGR Docket No. 70877-703.601together with a substituent of L1with the intervening atoms to form C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRc-, -NRcSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O-, -NRcC(=O)O-, -NRcC(=O)S-, -NRcC(=S)O-, -C(=O)NRc-, -NRcC(=O)NRc-, -NRcC(=S)NRc-, -C(=S)NRc- -S(=O)2NRa-, -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, C1-C6alkylene, C1-C6heteroalkylene, C2-C6alkenylene, C2-C6alkynylene, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;X is N or C;Y is N or C;V is N, C, or CRV;W is N, NRWN, C, CRW, C(RW)2, -S-, or -O-;RVis hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15WSGR Docket No. 70877-703.601membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;U is N, NRUN, CRU, C(RU)2, -S-, or -O-;each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Ruare taken together to form an oxo, thioxo, =NH, or =N- Ci-C3alkyl;RUNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), - N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, - C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, - C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci- C3alkyl)2, Ci-Csalkyl, Ci-Csalkoxy, C1-C3haloalkyl, C1-C3haloalkoxy, Ci-Cshydroxyalkyl, Ci- Csaminoalkyl, Ci-Csheteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C,-C’i aryl. Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ1is taken together with RWor RWNwith the intervening atoms to form Ring D;Z2 is CRZ2or N;WSGR Docket No. 70877-703.601RZ2is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Z3is CRZ3or N;RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ3is taken together with one R3and the intervening atoms to form Ring E;Z4is CRZ4or N;RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ4is taken together with RUor RUNwith the intervening atoms to form Ring C;Ring B is 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SFs, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, - S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C,-C’i aryl. 5-15 membered heteroaryl, C3-Ci5cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl,WSGR Docket No. 70877-703.601alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two Rs on the same atom form an oxo, thioxo, =NH, or =N-Ci-Csalkyl;p is 0, 1, 2, 3, 4, 5, 6, 7, or 8;Ring C is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more Rc;Ring D is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RD;Ring E is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RE;Ring F is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RF;provided that (i) at least one of Ring C, Ring D, Ring E and Ring F is present, or that two of RG1, RG2and RG3on adjacent atoms are taken together with the atoms to which they are attached to form a C6-C15aryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, and (ii) Ring C and Ring D are not both present;each of Rc, RD, RE, and RFis independently -halogen, -CN, -OH, -ORa, -SFs, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, - OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs- Ciscycloalkyl, Ce-Cisaryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two RC, two RD, and two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl;each Rais independently C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;WSGR Docket No. 70877-703.601Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-Csalkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci- Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, heterocycloalkyl, or C3- C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2C1-C3alkyl, -S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)2N(C1-C3alkyl)2, -S(=O)(=NC1-C3alkyl)(C1-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci- C1-C3heteroalkyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0005] In some embodiments, provided herein are compounds of Formula (I), or a pharmaceutically acceptable salt, or stereoisomer thereof:Formula (I),wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci- Chaloalkyl. Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2- Cealkynyl, C\-Ci cycloalkyl. 4-15 membered heterocycloalkyl, C -C’i aryl. or 5-15 memberedWSGR Docket No. 70877-703.601heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG2or RG3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RG1is hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, - NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C, -Ci aryl, 5- 15 membered heteroaryl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F;or two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; orone of RN1, RN2, and RN3and one of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SFs, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cdtaloalkyl. Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, C2-C4alkenyl, C2-C4alkynyl, Ci-Csheteroalkyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or one R2is taken together with a substituent of L1with the intervening atoms to form C -C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;WSGR Docket No. 70877-703.601each of L1and L2is independently absent, -O-, -S-, -NRc-, -NRcSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O-, -NRcC(=O)O-, -NRcC(=O)S-, -NRcC(=S)O-, -C(=O)NRc-, -NRcC(=O)NRc-, -NRcC(=S)NRc-, -C(=S)NRc- -S(=O)2NRa-, -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, C1-C6alkylene, C1-C6heteroalkylene, C2-C6alkenylene, C2-C6alkynylene, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C6-C15aryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;X is N or C;Y is N or C;V is N, C, or CRV;W is N, NRWN, C, CRW, C(RW)2, -S-, or -O-;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SFs, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl,WSGR Docket No. 70877-703.601heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;U is N, NRUN, CRU, C(RU)2, -S-, or -O-;each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Ruare taken together to form an oxo, thioxo, =NH, or =N- Ci-C3alkyl;RUNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), - N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, - C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, - C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci- CsalkylR. Ci-Galkyl. Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci- Csaminoalkyl, Ci-Csheteroalkyl, CS-C’salkcnyl. CS-Calkynyl. C,-C’i aryl. Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ1is taken together with RWor RWNwith the intervening atoms to form Ring D;Z2is CRZ2or N;RZ2is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci- Csheteroalkyl, C2-Csalkenyl, CS-C’salkynyl. Ce-Cisaryl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Z3is CRZ3or N;WSGR Docket No. 70877-703.601RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ3is taken together with one R3and the intervening atoms to form Ring E;Z4is CRZ4or N;RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ4is taken together with RUor RUNwith the intervening atoms to form Ring C;Ring B is 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SFs, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, - S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7, or 8;Ring C is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more Rc;Ring D is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RD;WSGR Docket No. 70877-703.601Ring E is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RE;Ring F is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RF;provided that (i) at least one of Ring C, Ring D, Ring E and Ring F is present, or that two of RG1, RG2and RG3on adjacent atoms are taken together with the atoms to which they are attached to form a C6-C15aryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, and (ii) Ring C and Ring D are not both present;each of Rc, RD, RE, and RFis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, - OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C15cycloalkyl, C6-C15aryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two RC, two RD, and two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl;each Rais independently C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHC1-C3alkyl, -N(C1-C3alkyl)2, C1-C3alkyl, C1-C3alkoxy, C1-C3haloalkyl, C1-C3haloalkoxy, C1-C3hydroxyalkyl, C1-C3aminoalkyl, C1-C3heteroalkyl, heterocycloalkyl, or C3-WSGR Docket No. 70877-703.601C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci- C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci- C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, Ce-Cis aryl, 5-15 membered heteroaryl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0006] In some embodiments, also provided herein are compounds of Formula (II), or a pharmaceutically acceptable salt, or stereoisomer thereof:wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG1, RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, - S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci- Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ci5cycloalkyl, 4-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a C,-C’i aryl. C5- Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or two RG1, RG2or RG3, on the same atom are taken together to form an oxo, thioxo, =NH, or =N-C1-C3alkyl;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, whereinWSGR Docket No. 70877-703.601the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, C2-C4alkenyl, C2-C4alkynyl, Ci-Csheteroalkyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is an integer from 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRc-, -NRcSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O-, -NRcC(=O)O-, -NRcC(=O)S-, -NRcC(=S)O-, -S(=O)2-, -C(=O)NRc-, -NRcC(=O)NRc-, -NRcC(=S)NRc-, -C(=S)NRc-, -S(=O)2NRa-, -OP(=O)(ORa)NRb-, -OP(=O)(NRaRb)O-, -NRc(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, C1-C6alkylene, C1-C6heteroalkylene, C2-C6alkenylene, C2-C6alkynylene, C6-C10aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciocycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;each ' is independently a single bond or a double bond;WSGR Docket No. 70877-703.601Ring G is a 5 membered heterocycloalkyl or 5-6 membered heteroaryl comprising ring members Y, X, W, and V;X and Y are each independently C or N;V is CH, C, orN;W is C, CRW, C(RW)2, N, NRWN, -S-, or -O-;wherein, when (i) W is NRWNand ring G is a pyrrole, or (ii) W is NRWN, X is C, Y is C, and ring G is an imidazole, then the 6-membered ring comprising G1, G2, G3, X and Y is a pyridone;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SH, -SRa, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkyl-C3-C6cycloalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;each R5is independently C1-C3alkyl, C1-C3alkoxy, C1-C3haloalkyl, C1-C3haloalkoxy, C1-C3hydroxyalkyl, C1-C3aminoalkyl, or C1-C3heteroalkyl; or two R5are taken together to form an oxo;q is 0, 1, or 2;L3is C1-C6alkynylene, C6-C10aryl, C3-C10heteroaryl, C4-C10heterocycloalkyl, or C3-C10cycloalkyl, wherein the aryl, heteroaryl, heterocycloalkyl, or cycloalkyl is optionally substituted with one or more R;Ring B is 5-15 membered heteroaryl or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7, or 8;each Rais independently C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-WSGR Docket No. 70877-703.601C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHC1-C3alkyl, -N(C1-C3alkyl)2, C1-C3alkyl, C1-C3alkoxy, C1-C3haloalkyl, C1-C3haloalkoxy, C1-C3hydroxyalkyl, C1-C3aminoalkyl, C1-C3heteroalkyl, or C3-C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2C1-C3alkyl, -S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)2N(C1-C3alkyl)2, -S(=O)(=NC1-C3alkyl)(C1-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci- Csheteroalkyl, C\-Ci cycloalkyl. 4-15 membered heterocycloalkyl, C-Ci aryl, 5-15 membered heteroaryl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0007] In some embodiments, provided herein are compounds of Table 1, Table 2, and Table 3.
[0008] In some embodiments, provided herein are pharmaceutical compositions comprising the compounds provided herein, or a pharmaceutically acceptable salt, or stereoisomer thereof, and optionally a pharmaceutically acceptable excipient.
[0009] In some embodiments, provided herein are methods of modulating IL-4 or IL- 13 in a subject in need thereof, the method comprising administering to the subject an effective amount of the compounds provided herein, or a pharmaceutically acceptable salt, or stereoisomer thereof, or a pharmaceutical composition provided herein.
[0010] In some embodiments, provided herein are methods of treating a disease modulated by L-4 or IL-13 in a subject in need thereof, the method comprising administering to the subject an effective amountWSGR Docket No. 70877-703.601of the compounds provided herein, or a pharmaceutically acceptable salt, or stereoisomer thereof, or a pharmaceutical composition provided herein. The disease may be an inflammatory disorder, an autoimmune condition, a fibrotic condition, or cancer.INCORPORATION BY REFERENCE
[0011] All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.DETAILED DESCRIPTIONDefinitions
[0012] In the following description, certain specific details are set forth to provide a thorough understanding of various embodiments. However, one skilled in the art will understand that the invention may be practiced without these details. In other instances, well-known structures have not been shown or described in detail to avoid unnecessarily obscuring descriptions of the embodiments. Unless the context requires otherwise, throughout the specification and claims which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense, that is, as “including, but not limited to.” Further, headings provided herein are for convenience only and do not interpret the scope or meaning of the claimed invention.
[0013] Reference throughout this specification to “some embodiments” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments. Also, as used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. It should also be noted that the term “or” is generally employed in its sense including “and / or” unless the content clearly dictates otherwise.
[0014] The terms below, as used herein, have the following meanings, unless indicated otherwise:
[0015] ‘ ‘oxo” refers to =0.
[0016] ‘ ‘thiooxo” or “thioxo” refers to =S.
[0017] “Carboxyl” refers to -COOH.
[0018] “Cyano” refers to -CN.
[0019] “Alkyl” refers to a straight-chain, or branched-chain saturated hydrocarbon monoradical having from one to about ten carbon atoms, more preferably one to six carbon atoms. Examples include, but are not limited to methyl, ethyl, n-propyl, isopropyl, 2 -methyl- 1 -propyl, 2 -methyl -2 -propyl, 2-methyl-l-butyl, 3 -methyl- 1 -butyl, 2-methyl-3-butyl, 2,2-dimethyl-l -propyl, 2-methyl-l -pentyl, 3 -methyl- 1 -pentyl, 4-methyl-l -pentyl, 2 -methyl -2 -pentyl, 3 -methyl -2 -pentyl, 4-methyl -2 -pentyl, 2,2-dimethyl-l -butyl, 3,3-WSGR Docket No. 70877-703.601dimethyl- 1 -butyl, 2 -ethyl- 1 -butyl, n-butyl, isobutyl, sec-butyl, t-butyl, n-pentyl, isopentyl, neopentyl, tert-amyl and hexyl, and longer alkyl groups, such as heptyl, octyl and the like. Whenever it appears herein, a numerical range such as “Ci-Ce alkyl” or “Ci-ealkyl”, means that the alkyl group may consist of 1 carbon atom, 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, although the present definition also covers the occurrence of the term “alkyl” where no numerical range is designated. In some embodiments, the alkyl is a Ci-ioalkyl. In some embodiments, the alkyl is a Ci-ealkyl. In some embodiments, the alkyl is a Ci-salkyl. In some embodiments, the alkyl is a Ci-4alkyl. In some embodiments, the alkyl is a Ci-salkyl. Unless stated otherwise specifically in the specification, an alkyl group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, carboxyl, carboxylate, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, the alkyl is optionally substituted with oxo, halogen, -CN, -COOH, -COOMe, -OH, -OMe, -NH2, or -NO2. In some embodiments, the alkyl is optionally substituted with halogen, -CN, -OH, or -OMe. In some embodiments, the alkyl is optionally substituted with halogen.
[0020] “Alkenyl” refers to a straight-chain, or branched-chain hydrocarbon monoradical having one or more carbon-carbon double-bonds and having from two to about ten carbon atoms, more preferably two to about six carbon atoms. The group may be in either the cis or trans conformation about the double bond(s), and should be understood to include both isomers. Examples include, but are not limited to ethenyl (-CH=CH2), 1-propenyl (-CH2CH=CH2), isopropenyl [-C(CH3)=CH2], butenyl, 1,3-butadienyl and the like. Whenever it appears herein, a numerical range such as “C2-C6 alkenyl” or “C2-6alkenyl”, means that the alkenyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, although the present definition also covers the occurrence of the term “alkenyl” where no numerical range is designated. Unless stated otherwise specifically in the specification, an alkenyl group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, carboxyl, carboxylate, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, the alkenyl is optionally substituted with oxo, halogen, -CN, -COOH, -COOMe, -OH, -OMe, -NH2, or -NO2. In some embodiments, the alkenyl is optionally substituted with halogen, -CN, -OH, or -OMe. In some embodiments, the alkenyl is optionally substituted with halogen.
[0021] “Alkynyl” refers to a straight-chain or branched-chain hydrocarbon monoradical having one or more carbon-carbon triple-bonds and having from two to about ten carbon atoms, more preferably from two to about six carbon atoms. Examples include, but are not limited to ethynyl, 2-propynyl, 2-butynyl, 1,3-butadiynyl and the like. Whenever it appears herein, a numerical range such as “C2-C6 alkynyl” or “C2-6alkynyl”, means that the alkynyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, although the present definition also covers the occurrence of the term “alkynyl” where no numerical range is designated. Unless stated otherwise specifically in the specification, an alkynyl group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, carboxyl, carboxylate, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, the alkynyl is optionally substituted with oxo, halogen, -CN, -COOH, COOMe, -OH, -OMe, -NH2, or -NO2. In some embodiments, the alkynyl is optionallyWSGR Docket No. 70877-703.601substituted with halogen, -CN, -OH, or -OMe. In some embodiments, the alkynyl is optionally substituted with halogen.
[0022] “Alkylene” refers to a straight or branched divalent hydrocarbon chain. Unless stated otherwise specifically in the specification, an alkylene group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, carboxyl, carboxylate, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, the alkylene is optionally substituted with oxo, halogen, -CN, -C00H, COOMe, -OH, -OMe, -NH2, or -NO2. In some embodiments, the alkylene is optionally substituted with halogen, -CN, -OH, or -OMe. In some embodiments, the alkylene is optionally substituted with halogen.
[0023] “Alkoxy” refers to a radical of the formula -Oalkyl where alkyl is as defined above. Unless stated otherwise specifically in the specification, an alkoxy group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, carboxyl, carboxylate, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, the alkoxy is optionally substituted with halogen, -CN, -C00H, COOMe, -OH, -OMe, -NH2, or -NO2. In some embodiments, the alkoxy is optionally substituted with halogen, -CN, -OH, or -OMe. In some embodiments, the alkoxy is optionally substituted with halogen.
[0024] “Aryl” refers to a radical derived from a hydrocarbon ring system comprising 6 to 30 carbon atoms and at least one aromatic ring. The aryl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocycloalkyl ring, the aryl is bonded through an aromatic ring atom), spiro, or bridged ring systems. In some embodiments, the aryl is a 6- to 10-membered aryl. In some embodiments, the aryl is a 6-membered aryl (phenyl). Aryl radicals include, but are not limited to, aryl radicals derived from the hydrocarbon ring systems of anthrylene, naphthylene, phenanthrylene, anthracene, azulene, benzene, chrysene, fluoranthene, fluorene, as-indacene, s-indacene, indane, indene, naphthalene, phenalene, phenanthrene, pleiadene, pyrene, and triphenylene. In some embodiments, an aryl as described herein is monocyclic. In some embodiments, an aryl as described herein is polycyclic. In some embodiments, an aryl as described herein is bicyclic. In some embodiments, an aryl as described herein is tricyclic. In some embodiments, an aryl as described herein comprises fused rings. In some embodiments, an aryl as described herein is a polycyclic ring that comprises a phenyl ring fused with a C5-C15 cycloalkyl. In some embodiments, an aryl as describedherein is a polycyclic ring that comprises a phenyl ring fused with a C5-C10 cycloalkyl (e.g.,,insome embodiments, an aryl as described herein is apolycyclic ring that comprises a phenyl ring fused with a Cs-Ce cycloalkyl (e.g.,). In some embodiments, an aryl as described herein is a polycyclic ring that comprises a phenyl ring fused with a 5-15 membered heterocycloalkyl. In some embodiments, an aryl as described herein is a polycyclic ring that comprises a phenyl ring fused with 5-10 membered heterocycloalkyl (e.g.,WSGR Docket No. 70877-703.601In some embodiments, an aryl as described herein is a polycyclic ring that comprises a phenyl ring fused with 5-6 membered heterocycloalkyl (e.g.,Unless stated otherwise specifically in the specification, an aryl may be optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, carboxyl, carboxylate, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, the aryl is optionally substituted with halogen, methyl, ethyl, -CN, -COOH, COOMe, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, the aryl is optionally substituted with halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the aryl is optionally substituted with halogen.
[0025] “Cycloalkyl” refers to a partially or fully saturated, monocyclic, or polycyclic carbocyclic ring, which may include fused (when fused with an aryl or a heteroaryl ring, the cycloalkyl is bonded through a non-aromatic ring atom), spiro, or bridged ring systems. In some embodiments, the cycloalkyl is fully saturated. Representative cycloalkyls include, but are not limited to, cycloalkyls having from three to fifteen carbon atoms (e.g., C3-C15 fully saturated cycloalkyl or C3-C15 cycloalkenyl), from three to ten carbon atoms (e.g., C3-C10 fully saturated cycloalkyl or C3-C10 cycloalkenyl), from three to eight carbon atoms (e.g., C3-C8 fully saturated cycloalkyl or C3-C8 cycloalkenyl), from three to six carbon atoms (e.g., C3-C6 fully saturated cycloalkyl or C3-C6 cycloalkenyl), from three to five carbon atoms (e.g., C3-C5 fully saturated cycloalkyl or C3-C5 cycloalkenyl), or three to four carbon atoms (e.g., C3-C4 fully saturated cycloalkyl or C3-C4 cycloalkenyl). In some embodiments, the cycloalkyl is a 3- to 10-membered fully saturated cycloalkyl or a 3- to 10-membered cycloalkenyl. In some embodiments, the cycloalkyl is a 3 - to 6-membered fully saturated cycloalkyl or a 3- to 6-membered cycloalkenyl. In some embodiments, the cycloalkyl is a 5- to 6-membered fully saturated cycloalkyl or a 5- to 6-membered cycloalkenyl.Monocyclic cycloalkyls include, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Polycyclic cycloalkyls include, for example, adamantyl, norbomyl, decalinyl, bicyclo[3.3.0]octane, bicyclo[4.3.0]nonane, cis-decalin, trans-decalin, bicyclo [2.1.1] hexane, bicyclo [2.2.1] heptane, bicyclo[2.2.2]octane, bicyclo[3.2.2]nonane, and bicyclo [3.3.2] decane, and 7,7- dimethyl-bicyclo[2.2.1]heptanyl. Partially saturated cycloalkyls include, for example cyclopentenyl, cyclohexenyl, cycloheptenyl, and cyclooctenyl. In some embodiments, a cycloalkyl as described herein is monocyclic. In some embodiments, a cycloalkyl as described herein is polycyclic. In some embodiments, a cycloalkyl as described herein is bicyclic. In some embodiments, a cycloalkyl as described herein is tricyclic. In some embodiments, a cycloalkyl as described herein comprises fused rings. In some embodiments, a cycloalkyl as described herein comprises spirocyclic rings. In some embodiments, a cycloalkyl as described herein comprises bridged rings. In some embodiments, a cycloalkyl as described herein is a polycyclic ring that comprises a partially or fully saturated, monocyclic, or polycyclic carbocyclic ring fused with an aryl or a heteroaryl. In some embodiments, a cycloalkyl as described herein is a polycyclic ring that comprises a partially or fully saturated,WSGR Docket No. 70877-703.601monocyclic, or polycyclic carbocyclic ring fused with an aryl (e.g., orsome embodiments, a cycloalkyl as described herein is a polycyclic ring that comprises a partially orfully saturated, monocyclic, or polycyclic carbocyclic ring fused with a heteroaryl (e.g.,orUnless stated otherwise specifically in the specification, a cycloalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, carboxyl, carboxylate, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -COOH, COOMe, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the cycloalkyl is optionally substituted with halogen.
[0026] “Halo” or “halogen” refers to bromo, chloro, fluoro or iodo. In some embodiments, halogen is fluoro or chloro. In some embodiments, halogen is fluoro.
[0027] “Haloalkyl” refers to an alkyl radical, as defined above, that is substituted by one or more halo radicals, as defined above, e.g., trifluoromethyl, difluoromethyl, fluoromethyl, trichloromethyl, 2,2,2- trifluoroethyl, 1,2-difluoroethyl, 3 -bromo-2 -fluoropropyl, 1,2-dibromoethyl, and the like.
[0028] “Hydroxyalkyl” refers to an alkyl radical, as defined above, that is substituted by one or more hydroxyls. In some embodiments, the alkyl is substituted with one hydroxyl. In some embodiments, the alkyl is substituted with one, two, or three hydroxyls. Hydroxyalkyl include, for example, hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl, or hydroxypentyl. In some embodiments, the hydroxyalkyl is hydroxymethyl.
[0029] “Aminoalkyl” refers to an alkyl radical, as defined above, that is substituted by one or more amines. In some embodiments, the alkyl is substituted with one amine. In some embodiments, the alkyl is substituted with one, two, or three amines. Aminoalkyl include, for example, aminomethyl, aminoethyl, aminopropyl, aminobutyl, or aminopentyl. In some embodiments, the aminoalkyl is aminomethyl.
[0030] “Heteroalkyl” refers to an alkyl group in which one or more skeletal atoms of the alkyl are selected from an atom other than carbon, e.g., oxygen, nitrogen (e.g., -NH-, -N(alkyl)-), sulfur, phosphorus, or combinations thereof. A heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. In one aspect, a heteroalkyl is a Ci-Ce heteroalkyl wherein the heteroalkyl is comprised of 1 to 6 carbon atoms and one or more atoms other than carbon, e.g., oxygen, nitrogen (e.g. - NH-, -N(alkyl)-), sulfur, phosphorus, or combinations thereof wherein the heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. Examples of such heteroalkyl are, for example, - CH2OCH3, -CH2CH2OCH3, -CH2CH2OCH2CH2OCH3, -CH(CH3)OCH3, -CH2NHCH3, -CH2N(CH3)2, - CH2CH2NHCH3, or -CH2CH2N(CH3)2. Unless stated otherwise specifically in the specification, a heteroalkyl is optionally substituted for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In someWSGR Docket No. 70877-703.601embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the heteroalkyl is optionally substituted with halogen.
[0031] “Heterocycloalkyl” refers to a 3 - to 24-membered partially or fully saturated ring radical comprising 2 to 23 carbon atoms and from one to 8 heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous, silicon, and sulfur. In some embodiments, the heterocycloalkyl is fully saturated. In some embodiments, the heterocycloalkyl comprises one to three heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur. In some embodiments, the heterocycloalkyl comprises one to three heteroatoms selected from the group consisting of nitrogen and oxygen. In some embodiments, the heterocycloalkyl comprises one to three nitrogens. In some embodiments, the heterocycloalkyl comprises one or two nitrogens. In some embodiments, the heterocycloalkyl comprises one nitrogen. In some embodiments, the heterocycloalkyl comprises one nitrogen and one oxygen.Unless stated otherwise specifically in the specification, the heterocycloalkyl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with an aryl or a heteroaryl ring, the heterocycloalkyl is bonded through a non-aromatic ring atom), spiro, or bridged ring systems; and the nitrogen, carbon, or sulfur atoms in the heterocycloalkyl radical may be optionally oxidized; the nitrogen atom may be optionally quatemized. Representative heterocycloalkyls include, but are not limited to, heterocycloalkyls having from two to fifteen carbon atoms (e.g., C2-C15 fully saturated heterocycloalkyl or C2-C15 heterocycloalkenyl), from two to ten carbon atoms (e.g., C2-C10 fully saturated heterocycloalkyl or C2-C10 heterocycloalkenyl), from two to eight carbon atoms (e.g., C2-C8fully saturated heterocycloalkyl or C2-C8 heterocycloalkenyl), from two to seven carbon atoms (e.g., C2-C7 fully saturated heterocycloalkyl or C2-C7 heterocycloalkenyl), from two to six carbon atoms (e.g., C2-C6 fully saturated heterocycloalkyl or C2-C7 heterocycloalkenyl), from two to five carbon atoms (e.g., C2-C5 fully saturated heterocycloalkyl or C2-C5 heterocycloalkenyl), or two to four carbon atoms (e.g., C2-C4 fully saturated heterocycloalkyl or C2-C4 heterocycloalkenyl). In some embodiments, a heterocycloalkyl comprises a carbon-carbon double bond in the ring (i.e., a heterocycloalkenyl). In some embodiments, a heterocycloalkyl comprises a double bond in the ring that is formed with one or moreheteroatoms (e.g., -CH=N- as shown in, or -S(=O)(methyl)=N- as shown in). Examples of such heterocycloalkyl radicals include, but are not limited to, aziridinyl, azetidinyl, oxetanyl, dioxolanyl, thienyl[l,3]dithianyl, decahydroisoquinolyl, imidazolinyl, imidazolidinyl, isothiazolidinyl, isoxazolidinyl, morpholinyl, octahydroindolyl, octahydroisoindolyl, 2-oxopiperazinyl, 2-oxopiperidinyl, 2-oxopyrrolidinyl, oxazolidinyl, piperidinyl, piperazinyl, 4-piperidonyl, pyrrolidinyl, pyrazolidinyl, quinuclidinyl, thiazolidinyl, tetrahydrofuryl, trithianyl, tetrahydropyranyl, thiomorpholinyl, thiamorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxo-thiomorpholinyl, 1,3-dihydroisobenzofuran-l-yl, 3-oxo-l,3-dihydroisobenzofuran-l-yl, methyl-2-oxo-l,3-dioxol-4-yl, and 2-oxo-l,3-dioxol-4-yl. The term heterocycloalkyl also includes all ring forms of the carbohydrates, including but not limited to theWSGR Docket No. 70877-703.601monosaccharides, the disaccharides, and the oligosaccharides. In some embodiments, heterocycloalkyls have from 2 to 10 carbons in the ring. It is understood that when referring to the number of carbon atoms in a heterocycloalkyl, the number of carbon atoms in the heterocycloalkyl is not the same as the total number of atoms (including the heteroatoms) that make up the heterocycloalkyl (i.e. skeletal atoms of the heterocycloalkyl ring). In some embodiments, the heterocycloalkyl is a 3- to 8-membered heterocycloalkyl. In some embodiments, the heterocycloalkyl is a 3 - to 7-membered heterocycloalkyl. In some embodiments, the heterocycloalkyl is a 3 - to 6-membered heterocycloalkyl. In some embodiments, the heterocycloalkyl is a 4- to 6-membered heterocycloalkyl. In some embodiments, the heterocycloalkyl is a 5- to 6-membered heterocycloalkyl. In some embodiments, the heterocycloalkyl is a 3- to 8-membered heterocycloalkenyl. In some embodiments, the heterocycloalkyl is a 3- to 7-membered heterocycloalkenyl. In some embodiments, the heterocycloalkyl is a 3 - to 6-membered heterocycloalkenyl. In some embodiments, the heterocycloalkyl is a 4- to 6-membered heterocycloalkenyl. In some embodiments, the heterocycloalkyl is a 5 - to 6-membered heterocycloalkenyl. In some embodiments, a heterocycloalkyl as described herein is monocyclic. In some embodiments, a heterocycloalkyl as described herein is polycyclic. In some embodiments, a heterocycloalkyl as described herein is bicyclic. In some embodiments, a heterocycloalkyl as described herein is tricyclic. In some embodiments, a heterocycloalkyl as described herein comprises fused rings. In some embodiments, a heterocycloalkyl as described herein comprises spirocyclic rings. In some embodiments, a heterocycloalkyl as described herein comprises bridged rings. In some embodiments, a heterocycloalkyl as described herein comprises a fused aryl or heteroaryl. For example, in some embodiments, a heterocycloalkyl as described herein is a polycyclic ring that comprises a fused aryl (e.g.,) |n Some embodiments, a heterocycloalkyl as described herein is a polycyclicring that comprises a fused heteroaryl (e.g.,). In some embodiments, a heterocycloalkyl as described herein comprises a point of attachment on a heteroatom (e.g., N, S), e.g., as Yin. In some embodiments, a heterocycloalkyl as described herein comprises a point of attachment on carbon atom. Unless stated otherwise specifically in the specification, a heterocycloalkyl may be optionally substituted as described below, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, carboxyl, carboxylate, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, the heterocycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -COOH, COOMe, -CFs, -OH, -OMe, -NH2, or -NO2. In some embodiments, the heterocycloalkyl is optionally substituted with halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the heterocycloalkyl is optionally substituted with halogen.
[0032] “Heteroaryl” refers to a 5- to 30-membered ring system radical comprising one to 29 carbon atoms, one to ten heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous, andWSGR Docket No. 70877-703.601sulfur, and at least one aromatic ring. In some embodiments, the heteroaryl comprises one to three heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur. In some embodiments, the heteroaryl comprises one to three heteroatoms selected from the group consisting of nitrogen and oxygen. In some embodiments, the heteroaryl comprises one to three nitrogens. In some embodiments, the heteroaryl comprises one or two nitrogens. In some embodiments, the heteroaryl comprises one nitrogen. The heteroaryl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocycloalkyl ring, the heteroaryl is bonded through an aromatic ring atom), spiro, or bridged ring systems; and the nitrogen, carbon, or sulfur atoms in the heteroaryl radical may be optionally oxidized; the nitrogen atom may be optionally quatemized. In some embodiments, the heteroaryl is a 5 - to 10-membered heteroaryl. In some embodiments, the heteroaryl is a 5- to 6-membered heteroaryl. In some embodiments, the heteroaryl is a 6-membered heteroaryl. In some embodiments, the heteroaryl is a 5 -membered heteroaryl. In some embodiments, a heteroaryl as described herein is monocyclic. In some embodiments, a heteroaryl as described herein is polycyclic. In some embodiments, a heteroaryl as described herein is bicyclic. In some embodiments, a heteroaryl as described herein is tricyclic. In some embodiments, a heteroaryl as described herein comprises fused rings. In some embodiments, a heteroaryl as described herein comprises spirocyclic rings. In some embodiments, a heteroaryl as described herein comprises bridged rings. In some embodiments, a heteroaryl as described herein is a polycyclic ring that comprises a heteroaromatic ring fused with a C5-C15 cycloalkyl. In some embodiments, a heteroaryl as described herein is a polycyclicring that comprises a heteroaromatic ring fused with a C5-C10 cycloalkyl (e.g.,In some embodiments, a heteroaryl as described herein is apolycyclic ring that comprises a heteroaromatic ring fused with a C -C, cycloalkyl (e.g.,In some embodiments, a heteroaryl as described herein is a polycyclic ring that comprises a heteroaromatic ring fused with a 5-15 membered heterocycloalkyl. In some embodiments, a heteroaryl as described herein is a polycyclic ring that comprises a heteroaromatic ring fused with 5-10membered heterocycloalkyl (e.g.,In some embodiments, a heteroaryl as described herein is a polycyclic ring that comprises a heteroaromatic ringfused with 5-6 membered heterocycloalkyl (e.g.,). Examples include, but are not limited to, azepinyl, acridinyl, benzimidazolyl, benzothiazolyl, benzindolyl, benzodioxolyl, benzofuranyl, benzooxazolyl, benzothiazolyl, benzothiadiazolyl, benzo[b][l,4]dioxepinyl, 1,4-benzodioxanyl, benzonaphthofuranyl, benzoxazolyl, benzodioxolyl, benzodioxinyl, benzopyranyl, benzopyranonyl, benzofuranyl, benzofuranonyl, benzothienyl (benzothiophenyl), benzotriazolyl,WSGR Docket No. 70877-703.601benzo[4,6]imidazo[l,2-a]pyridinyl, carbazolyl, cinnolinyl, dibenzofuranyl, dibenzothiophenyl, furanyl, furanonyl, isothiazolyl, imidazolyl, indazolyl, indolyl, indazolyl, isoindolyl, indolinyl, isoindolinyl, isoquinolyl, indolizinyl, isoxazolyl, naphthyridinyl, oxadiazolyl, 2-oxoazepinyl, oxazolyl, oxiranyl, 1-oxidopyridinyl, 1-oxidopyrimidinyl, 1-oxidopyrazinyl, 1-oxidopyridazinyl, 1 -phenyl- IH-pyrrolyl, phenazinyl, phenothiazinyl, phenoxazinyl, phthalazinyl, pteridinyl, purinyl, pyrrolyl, pyrazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, quinazolinyl, quinoxalinyl, quinolinyl, quinuclidinyl, isoquinolinyl, tetrahydroquinolinyl, thiazolyl, thiadiazolyl, triazolyl, tetrazolyl, triazinyl, and thiophenyl (i.e., thienyl). Unless stated otherwise specifically in the specification, a heteroaryl may be optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, carboxyl, carboxylate, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, and the like. In some embodiments, the heteroaryl is optionally substituted with halogen, methyl, ethyl, -CN, -COOH, COOMe, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, the heteroaryl is optionally substituted with halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the heteroaryl is optionally substituted with halogen.
[0033] As used herein, for clarity, a pyridone (e.g., a pyridin-2-one, O'", wherein R can be hydrogen or a nitrogen atom substituent), pyrimidinone, or the like, such as a pyridone fused to an aryl orheteroaryl (e.g., 06", wherein R can be hydrogen or a nitrogen atom substituent), is considered a heteroaryl ring herein. In heteroaryl groups that contain one or more nitrogen atoms, the point of attachment can be a carbon or nitrogen atom, as valency permits. Heteroaryl bicyclic ring systems can include one or more heteroatoms in one or both rings. In bicyclic heteroaryl groups wherein one ring does not contain a heteroatom (e.g., indolyl, quinolinyl, and the like), the point of attachment can be on either ring, i.e., either the ring bearing a heteroatom (e.g., 2-indolyl) or the ring that does not contain a heteroatom (e.g., 5-indolyl). As used herein, the term "heteroarylene" as used by itself or as part of another group refers to a divalent radical derived from the heteroaryl group defined herein.
[0034] Exemplary 5-membered heteroaryl groups containing one heteroatom include, without limitation, pyrrolyl, furanyl, and thiophenyl. Exemplary 5-membered heteroaryl groups containing two heteroatoms include, without limitation, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, and isothiazolyl. Exemplary 5-membered heteroaryl groups containing three heteroatoms include, without limitation, triazolyl, oxadiazolyl, and thiadiazolyl. Exemplary 5-membered heteroaryl groups containing four heteroatoms include, without limitation, tetrazolyl. Exemplary 6-membered heteroaryl groups containing one heteroatom include, without limitation, pyridinyl. Exemplary 6-membered heteroaryl groups containing two heteroatoms include, without limitation, pyridazinyl, pyrimidinyl, and pyrazinyl. Exemplary 6-membered heteroaryl groups containing three or four heteroatoms include, without limitation, triazinyl and tetrazinyl, respectively. Exemplary 7-membered heteroaryl groups containingWSGR Docket No. 70877-703.601one heteroatom include, without limitation, azepinyl, oxepinyl, and thiepinyl. Exemplary 5,6-bicyclic heteroaryl groups include, without limitation, indolyl, isoindolyl, indazolyl, benzotriazolyl, benzothiophenyl, isobenzothiophenyl, benzofuranyl, benzoisofuranyl, benzimidazolyl, benzoxazolyl, benzisoxazolyl, benzoxadiazolyl, benzthiazolyl, benzisothiazolyl, benzthiadiazolyl, indolizinyl, and purinyl. Exemplary 6,6-bicyclic heteroaryl groups include, without limitation, naphthyridinyl, pteridinyl, quinolinyl, isoquinolinyl, cinnolinyl, quinoxalinyl, phthalazinyl, and quinazolinyl.
[0035] The term “optional” or “optionally” means that the subsequently described event or circumstance may or may not occur, and that the description includes instances where said event or circumstance occurs and instances in which it does not. For example, “optionally substituted alkyl” means either “alkyl” or “substituted alkyl” as defined above. Further, an optionally substituted group may be unsubstituted (e.g., -CH2CH3), fully substituted (e.g., -CF2CF3), mono-substituted (e.g., -CH2CH2F) or substituted at a level anywhere in-between fully substituted and mono-substituted (e.g., -CH2CHF2, -CH2CF3, -CF2CH3, -CFHCHF2, etc.). It will be understood by those skilled in the art with respect to any group containing one or more substituents that such groups are not intended to introduce any substitution or substitution patterns that are sterically impractical and / or synthetically non-feasible. Thus, any substituents described should generally be understood as having a maximum molecular weight of about 1,000 daltons, and more typically, up to about 700 daltons, or up to about 500 daltons.
[0036] An “optionally substituted” group, such as an optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl groups, refers to the respective group that is unsubstituted or substituted. In general, the term “substituted”, whether preceded by the term “optionally” or not, means that at least one hydrogen present on a group (e.g., a carbon or nitrogen atom) is replaced with a permissible substituent, e.g., a substituent which upon substitution results in a stable compound, e.g., a compound which does not spontaneously undergo transformation such as by rearrangement, cyclization, elimination, or other reaction. Unless otherwise indicated, a “substituted” group has a substituent at one or more substitutable positions of the group, and when more than one position in any given structure is substituted, the substituent can be the same or different at each position. Typically, when substituted, the optionally substituted groups herein can be substituted with 1-5 substituents. Substituents can be a carbon atom substituent, a nitrogen atom substituent, an oxygen atom substituent or a sulfur atom substituent, as applicable, each of which can be optionally isotopically labeled, such as deuterated. Two of the optional substituents can join to form a ring structure, such as an optionally substituted cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring. Substitution can occur on any available carbon, oxygen, or nitrogen atom, and can form a spirocyclic group. Typically, substitution herein does not result in an O-O, O-N, S-S, S-N (except SO2-N, -S(=O)(=N)-, or -N=S(=O)- bond), heteroatom-halogen, or -C(O)-S bond or three or more consecutive heteroatoms, with the exception of O-SO2-O, O-SO2-N, and N-SO2-N, except that some of such bonds or connections may be allowed if in a stable aromatic system.WSGR Docket No. 70877-703.601
[0037] In some embodiments, the permissible substituents herein include acyclic and cyclic, branched and unbranched, carbocyclic and heterocyclic, aromatic and non-aromatic substituents of organic compounds. The permissible substituents can be one or more and the same or different for appropriate organic compounds. For purposes of this disclosure, the heteroatoms such as nitrogen may have hydrogen substituents and / or any permissible substituents of organic compounds described herein which satisfy the valences of the heteroatoms. Substituents can include any substituents described herein, for example, a halogen, a hydroxyl, a carbonyl (such as a carboxyl, an alkoxycarbonyl, a formyl, or an acyl), a thiocarbonyl (such as a thioester, a thioacetate, or a thioformate), an alkoxy, a cycloalkoxy, a phosphoryl, a phosphate, a phosphonate, a phosphinate, an amino, an amido, an amidine, an imine, a cyano, a nitro, an azido, a sulfhydryl, an alkylthio, a sulfate, a sulfonate, a sulfamoyl, a sulfonamido, a sulfonyl, a heterocycloalkyl, an alkyl, an alkenyl, an alkynyl, a cycloalkyl, a heterocycloalkyl, an aralkyl, an aryl, or a heteroaryl, each of which can be further substituted, if appropriate.
[0038] Exemplary substituents include, but are not limited to, alkyl, alkenyl, alkynyl, aryl, heteroaryl, -alkylene-aryl, -arylene-alkyl, -alkylene-heteroaryl, -alkenylene-heteroaryl, -alkynylene-heteroaryl, — OH, hydroxyalkyl, haloalkyl, — O-alkyl, — O-haloalkyl, -alkylene-O-alkyl, — O-aryl, — O-alkylene-aryl, — O-heteroaryl, — O-alkylene-heteroaryl, — O-cycloalkyl, — O-heterocycloalkyl, acyl, — C(O)-alkyl, — C(O)-haloalkyl, — C(O)-aryl, — C(O)-alkylene-aryl, — C(O)-heteroaryl, — C(O)-alkylene-heteroaryl, — C(O)-cycloalkyl, — C(O) -heterocycloalkyl, halo, — NO2, — CN, — SF5, — C(O)OH, — C(O)O-alkyl, — C(O)O-aryl, — C(O)O— alkylene-aryl, — S(O)-alkyl, — S(O)2-alkyl, — S(O)-haloalkyl, — S(O)2-haloalkyl, — S(O)-aryl, — S(O)2-aryl, — S(O)-heteroaryl, — S(O)2-heteroaryl, — S-alkyl, — S-aryl, — S-heteroaryl, — S-alkylene-aryl, — S-alkylene-heteroaryl, — S(O)2-alkylene-aryl, — S(O)2-alkylene-heteroaryl, — S-cycloalkyl, — S-heterocycloalkyl, — S(O)-cycloalkyl, — S(O)-heterocycloalkyl, — S(O)2-cycloalkyl, — S(O)2-heterocycloalkyl, — S(O)(=NH)-alkyl, — S(O)(=NH)-haloalkyl, — S(O)(=NH)-aryl, — S(O)(=NH)-alkylene-aryl, — S(O)(=NH)-heteroaryl, — S(O)(=NH)-alkylene-heteroaryl, — S(O)(=NH)-cycloalkyl, — S(O)(=NH)-heterocycloalkyl, — S(O)(=N-alkyl)-alkyl, — S(O)(=N-alkyl)-haloalkyl, — S(O)(=N-alkyl)-aryl, — S(O)(=N-alkyl)-alkylene-aryl, — S(O)(=N-alkyl)-heteroaryl, — S(O)(=N-alkyl)-alkylene-heteroaryl, — S(O)(=N-alkyl)-cycloalkyl, — S(O)(=N-alkyl)-heterocycloalkyl, cycloalkyl, heterocycloalkyl, — O — C(O)-alkyl, — O — C(O)-aryl, — O — C(O)-cycloalkyl, — C(=N — CN)— NH2, — C(=NH)— NH2, — C(=NH)— NH(alkyl), — N(YI)(Y2), -alkylene-N(Yi)(Y2), — C(0)N(Y i)(Y2) and — S(O)2N(Y i)(Y2), wherein Y i and Y2can be the same or different and are independently selected from the group consisting of hydrogen, alkyl, haloalkyl, aryl, -alkylene-aryl, heteroaryl, -alkylene-heteroaryl, cycloalkyl, heterocycloalkyl, and Yi and Y2with the nitrogen they linked can form a heterocyclic ring.
[0039] Some examples of suitable substituents include, but not limited to, (Ci-Cs)alkyl groups, (C2-Cs)alkenyl groups, (C2-C8)alkynyl groups, (C3-Cio)cycloalkyl groups, halogen (F, Cl, Br or I), halogenated (Ci-Cs)alkyl groups (for example but not limited to — CF3), — O — (Ci-Cs)alkyl groups, — OH, — S — (Ci-Cs)alkyl groups, — SH, — NH(Ci-C8)alkyl groups, — N((Ci-C8)alkyl)2groups, — NH2, — C(0)NH2, — C(O)NH(C1-C8)alkyl groups, — C(O)N((Ci-C8)alkyl)2, — NHC(0)H, — NHC(O)(Ci-WSGR Docket No. 70877-703.601C8)alkyl groups, — NHC(O)(C3-C8)cycloalkyl groups, — N((Ci-C8)alkyl)C(O)H, — N((Ci-C8)alkyl)C(O)(Ci-C8)alkyl groups, — NHC(0)NH2, — NHC(O)NH(Ci-C8)alkyl groups, — N((Ci-C8)alkyl)C(O)NH2groups, — NHC(O)N((Ci-C8)alkyl)2groups, — N((Ci-C8)alkyl)C(O)N((Ci- C8)alkyl)2groups, — N((Ci-C8)alkyl)C(O)NH((Ci-C8)alkyl), — C(O)H, — C(O)(Ci-C8)alkyl groups, — CN, — NO2, — S(O)(Ci-C8)alkyl groups, — S(O)2(Ci-C8)alkyl groups, — S(O)2N((Ci-C8)alkyl)2groups, — S(O)2NH(Ci-C8)alkyl groups, — S(O)2NH(C3-C8)cycloalkyl groups, — S(O)2NH2groups, — NHS(O)2(Ci-C8)alkyl groups, — N((Ci-C8)alkyl)S(O)2(Ci-C8)alkyl groups, — (Ci-C8)alkyl-O— (Ci-C8)alkyl groups, — O — (Ci-C8)alkyl-0 — (Ci-C8)alkyl groups, — C(O)OH, — C(O)O(Ci-C8)alkyl groups, NHOH, NHO(Ci-C8)alkyl groups, — O-halogenated (Ci-C8)alkyl groups (for example but not limited to — OCF3), — S(O)2-halogenated (Ci-C8)alkyl groups (for example but not limited to — S(O)2CF3), — S-halogenated (Ci-C8)alkyl groups (for example but not limited to — SCF3), — (Ci-Ce) heterocycle (for example but not limited to pyrrolidine, tetrahydrofuran, pyran or morpholine), — (Ci-Ce) heteroaryl (for example but not limited to tetrazole, imidazole, furan, pyrazine or pyrazole), -phenyl, — NHC(O)O — (Ci-Ce)alkyl groups, — N((Ci-Ce)alkyl)C(O)O — (Ci-Ce)alkyl groups, — C(=NH) — (Ci-Ce)alkyl groups, — C(=NOH)— (Ci-C6)alkyl groups, or — C(=N— O— (Ci-C6)alkyl)-(Ci-C6)alkyl groups.
[0040] Exemplary carbon atom substituents include, but are not limited to, deuterium, halogen, -CN, -NO2, -N3, hydroxyl, alkoxy, cycloalkoxy, aryloxy, amino, monoalkyl amino, dialkyl amino, amide, sulfonamide, thiol, acyl, carboxylic acid, ester, sulfone, sulfoxide, alkyl, haloalkyl, alkenyl, alkynyl, C3-10 cycloalkyl, Ce-io aryl, 3-10 membered heterocycloalkyl, 5-10 membered heteroaryl, etc. For example, exemplary carbon atom substituents can include F, Cl, -CN, -SO2H, -SO3H, -SF5, -OH, -OC1-6 alkyl, -NH2, -N(CI-6 alkyl)2, -NH(C’i „ alkyl), -SH, — SC 1,, alkyl, -C(=O)(Ci-6 alkyl), -CO2H, -CO2(CIalkyl), -OC(=O)(CIalkyl), -OCO2(CIalkyl), -C(=O)NH2, -C(=O)N(CIalkyl)2, -OC(=O)NH(CIalkyl), -NHC(=O)(CIalkyl), -N(CI-6 alkyl)C(=O)( C,, alkyl), -NHCO2(CIalkyl), -NHC(=O)N(CIalkyl)2, -NHC(=O)NH(CIalkyl), -NHC(=0)NH2, -NHSO2(CIalkyl), -SCENIC alkyl)2, -SO2NH(CI_6 alkyl), -SO2NH2.-SO2C.. alkyl, -SO2OCi^ alkyl, -OSO2Ci^ alkyl, -SOC, alkyl, C alkyl, Ci^ haloalkyl, „ alkenyl, „ alkynyl, C3-10 cycloalkyl, Ce-io aryl, 3-10 membered heterocycloalkyl, 5-10 membered heteroaryl; or two geminal substituents can be joined to form =0.
[0041] Nitrogen atoms can be substituted or unsubstituted as valency permits, and include primary, secondary, tertiary, and quaternary nitrogen atoms. Exemplary nitrogen atom substituents include, but are not limited to, acyl groups, esters, sulfone, sulfoxide, C1-10 alkyl, C1-10 haloalkyl, C2-10 alkenyl, C2-10 alkynyl, C3-10 cycloalkyl, 3-14 membered heterocycloalkyl, Ce-i4 aryl, and 5-14 membered heteroaryl, or two substituent groups attached to a nitrogen atom are joined to form a 3-14 membered heterocycloalkyl or 5-14 membered heteroaryl ring, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl can be further substituted as defined herein. In certain embodiments, the substituent present on a nitrogen atom is a nitrogen protecting group (also referred to as an amino protecting group). Nitrogen protecting groups are well known in the art and include those described in detail in Protective Groups in Organic Synthesis, 4thed. P. G. M. Wuts; T. W. Greene, John Wiley, 2007, incorporated by reference herein. Exemplary nitrogen protecting groups include, but not limited to, those formingWSGR Docket No. 70877-703.601carbamates, such as Carbobenzyloxy (Cbz) group, p-Methoxybenzyl carbonyl (Moz or MeOZ) group, tert-Butyloxycarbonyl (BOC) group, Troc, 9-Fluorenylmethyloxycarbonyl (Fmoc) group, etc., those forming an amide, such as acetyl, benzoyl, etc., those forming a benzylic amine, such as benzyl, p-methoxybenzyl, 3,4-dimethoxybenzyl, etc., those forming a sulfonamide, such as tosyl, Nosyl, etc., and others such as p-methoxyphenyl.
[0042] Exemplary oxygen atom substituents include, but are not limited to, acyl groups, esters, sulfonates, Cuo alkyl, Ci-io haloalkyl, C2-10 alkenyl, C2-10 alkynyl, C3-10 cycloalkyl, 3-14 membered heterocycloalkyl, Ce-i4 aryl, and 5-14 membered heteroaryl, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl can be further substituted as defined herein. In certain embodiments, the oxygen atom substituent present on an oxygen atom is an oxygen protecting group (also referred to as a hydroxyl protecting group). Oxygen protecting groups are well known in the art and include those described in detail in Protective Groups in Organic Synthesis, 4thed. P. G. M. Wuts; T. W. Greene, John Wiley, 2007, incorporated herein by reference. Exemplary oxygen protecting groups include, but are not limited to, those forming alkyl ethers or substituted alkyl ethers, such as methyl, allyl, benzyl, substituted benzyls such as 4-methoxybenzyl, methoxylmethyl (MOM), benzyloxymethyl (BOM), 2-methoxyethoxymethyl (MEM), etc., those forming silyl ethers, such as trimethylsilyl (TMS), triethylsilyl (TES), triisopropylsilyl (TIPS), t-butyldimethylsilyl (TBDMS), etc., those forming acetals or ketals, such as tetrahydropyranyl (THP), those forming esters such as formate, acetate, chloroacetate, dichloroacetate, trichloroacetate, trifluoroacetate, methoxyacetate, etc., those forming carbonates or sulfonates such as methanesulfonate (mesylate), benzylsulfonate, and tosylate (Ts), etc.
[0043] In some embodiments, the “optionally substituted” alkyl(ene), heteroalkyl(ene), alkenyl(ene), alkynyl(ene), alkoxy, cycloalkyl, or heterocycloalkyl, herein can each be independently unsubstituted or substituted with 1-5 substituents independently selected from deuterium, halogen (e.g., F, Cl), -OH, CN, protected hydroxyl, oxo (as applicable), NH2, protected amino, NH(CI-4 alkyl) or a protected derivative thereof, N(CI-4 alkyl)(Ci-4 alkyl), C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 alkoxy, C3-6 cycloalkyl, C3-6 cycloalkoxy, phenyl, 5 or 6 membered heteroaryl containing 1, 2, or 3 ring heteroatoms independently selected from O, S, and N, 3-7 membered heterocycloalkyl containing 1 or 2 ring heteroatoms independently selected from O, S, and N (or substituted S or N, such as -S(=O)2- or -S(=O)(=N)-, or -N=S(=O)-), wherein each of the alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, phenyl, heteroaryl, and heterocycloalkyl, is optionally substituted with 1, 2, or 3 substituents independently selected from deuterium, F, -OH, oxo (as applicable), C1-4 alkyl, C1.4 haloalkyl (e.g., CF3), C1-4 alkoxy and fluorosubstituted C1-4 alkoxy. In some embodiments, the “optionally substituted” aryl, or heteroaryl group herein can each be independently unsubstituted or substituted with 1, 2, 3, or 4 substituents independently selected from deuterium, halogen (e.g., F, Cl), -OH, -CN, NH2, protected amino, NH(Cl-4alkyl) or a protected derivative thereof, N(Ci-4 alkyl)(Ci-4 alkyl), -S(=O)(Ci-4 alkyl), -SO2(Ci-4 alkyl), C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 alkoxy, C3-6 cycloalkyl, phenyl, 5 or 6 membered heteroaryl containing 1, 2 or 3 ring heteroatoms independently selected from O, S, and N, 3-7 membered heterocycloalkyl containing 1 or 2 ring heteroatoms independently selected from O, S, and N, wherein each of the alkyl, alkenyl,WSGR Docket No. 70877-703.601alkynyl, alkoxy, cycloalkyl, phenyl, heteroaryl, and heterocycloalkyl, is optionally substituted with 1, 2, or 3 substituents independently selected from deuterium, F, -OH, oxo (as applicable), Ci-4 alkyl, Ci-4 haloalkyl (e.g., -CFs), Ci-4 alkoxy and fluoro-substituted Ci-4 alkoxy. In any of the embodiments herein, unless otherwise specified or contrary from context, an optionally substituted group can be unsubstituted or substituted with 1-3 substituents each independently deuterium, F, -OH, Ci-4 alkyl optionally substituted with 1-3 F, Ci-4 alkoxy optionally substituted with 1-3 F, cyclopropyl, cyclobutyl, or O-cyclopropyl.
[0044] The term “one or more” when referring to an optional substituent means that the subject group is optionally substituted with one, two, three, four, or more substituents. In some embodiments, the subject group is optionally substituted with one, two, three or four substituents. In some embodiments, the subject group is optionally substituted with one, two, or three substituents. In some embodiments, the subject group is optionally substituted with one or two substituents. In some embodiments, the subject group is optionally substituted with one substituent. In some embodiments, the subject group is optionally substituted with two substituents.
[0045] An “effective amount” or “therapeutically effective amount” refers to an amount of a compound administered to a mammalian subject, either as a single dose or as part of a series of doses, which is effective to produce a desired therapeutic effect.
[0046] The terms “treat,” “treating” or “treatment,” as used herein, include alleviating, abating, or ameliorating at least one symptom of a disease or condition, preventing additional symptoms, inhibiting the disease or condition, e.g., arresting the development of the disease or condition, relieving the disease or condition, causing regression of the disease or condition, relieving a condition caused by the disease or condition, or stopping the symptoms of the disease or condition.Compounds
[0047] Described herein are compounds, or a pharmaceutically acceptable salt or stereoisomer thereof useful in the treatment of a disease or disorder associated with interleukin 4 (IL-4). Described herein are compounds, or a pharmaceutically acceptable salt or stereoisomer thereof useful in the treatment of a disease or disorder associated with interleukin 13 (IL-13). In some embodiments, described herein are compounds, or a pharmaceutically acceptable salt or stereoisomer thereof useful as signal transducer and activator of transcription 6 (STAT6) inhibitors.
[0048] In some embodiments, provided herein are compounds of Formula (I), or a pharmaceutically acceptable salt, or stereoisomer thereof:WSGR Docket No. 70877-703.601Formula (I),wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, - NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci- Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2- Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, C, -C’i aryl. or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG2or RG3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RG1is hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, - NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C, -Ci aryl, 5-15 membered heteroaryl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-Ci- Csalkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F;or two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; orone of RN1, RN2, and RN3and one of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-WSGR Docket No. 70877-703.601Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Cami noalky 1, C2-C4 alkenyl, C2-C4 alkynyl, Ci-Csheteroalkyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or one R2is taken together with a substituent of L1with the intervening atoms to form C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRC-, -NRcSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- - NRcC(=O)O- -NRcC(=O)S- -NRcC(=S)O- -C(=O)NRC- -NRcC(=O)NRc- -NRcC(=S)NRc- - C(=S)NRC- -S(=O)2NRa-, -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-C6alkylene, Ci- Ceheteroalkylene, C2-Cealkenylene, C2-Cealkynylene, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;X is N or C;Y is N or C;V is N, C, or CRV;W is N, NRWN, C, CRW, C(RW)2, -S-, or -O-;WSGR Docket No. 70877-703.601RVis hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;U is N, NRUN, CRU, C(RU)2, -S-, or -O-;each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Ruare taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RUNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), - N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, - C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, - C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci- C3alkyl)2, Ci-Csalkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci- Csaminoalkyl, Ci-Csheteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C,-C’i aryl. Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl,WSGR Docket No. 70877-703.601heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ1is taken together with RWor RWNwith the intervening atoms to form Ring D;Z2is CRZ2or N;RZ2is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Z3is CRZ3or N;RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ3is taken together with one R3and the intervening atoms to form Ring E;Z4 is CRZ4or N;RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ4is taken together with RUor RUNwith the intervening atoms to form Ring C;Ring B is 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -WSGR Docket No. 70877-703.601S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C,-Ci aryl, 5-15 membered heteroaryl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7, or 8;Ring C is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more Rc;Ring D is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RD;Ring E is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RE;Ring F is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RF;provided that (i) at least one of Ring C, Ring D, Ring E and Ring F is present, or that two of RG1, RG2and RG3on adjacent atoms are taken together with the atoms to which they are attached to form a C6-C15aryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, and (ii) Ring C and Ring D are not both present;each of Rc, RD, RE, and RFis independently -halogen, -CN, -OH, -ORa, -SFs, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, - OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15cycloalkyl, C6-C15aryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two RC, two RD, and two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl;each Rais independently C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-WSGR Docket No. 70877-703.601C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-Csalkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci- Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, heterocycloalkyl, or C3- C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2C1-C3alkyl, -S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)2N(C1-C3alkyl)2, -S(=O)(=NC1-C3alkyl)(C1-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci- C1-C3heteroalkyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0049] Disclosed herein is a compound of Formula (I), or a pharmaceutically acceptable salt, or stereoisomer thereof:Formula (I),wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2WSGR Docket No. 70877-703.601NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci- Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2- Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, C -C’i aryl. or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG1or RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RG1is hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, - NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C6-C15aryl, 5-15 membered heteroaryl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F;or two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;each of RN1, RN2, and RN3is independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; orone of RN1, RN2, and RN3and one of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SFs, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, C1-C3haloalkyl, C1-C3haloalkoxy, C1-C3hydroxyalkyl, C1-C3aminoalkyl, C2-C4 alkenyl, C2-C4 alkynyl, Ci-Csheteroalkyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or one R2is taken together with a substituent of L1with the intervening atoms to form C -C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;WSGR Docket No. 70877-703.601n is 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRc-, -NRcSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- -NRcC(=O)O- -NRcC(=O)S- -NRcC(=S)O- -C(=O)NRc- -NRcC(=O)NRc- -NRcC(=S)NRc- -C(=S)NRc- -S(=O)2NRa-, -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, C1-C6alkylene, C1-C6heteroalkylene, C2-C6alkenylene, C2-C6alkynylene, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C6-C15aryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;X is N or C;Y is N or C;V is N, C, or CRV;W is N, NRWN, C, CRW, C(RW)2, -S-, or -O-;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SFs, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo;WSGR Docket No. 70877-703.601RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;U is N, NRUN, CRU, C(RU)2, -S-, or -O-;each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Ruare taken together to form an oxo, thioxo, =NH, or =N- Ci-C3alkyl;RUNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), - N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, - C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, - C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci- C3alkyl)2, Ci-Csalkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci- Csaminoalkyl, Ci-Csheteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C,-C’i aryl. Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ1is taken together with RWor RWNwith the intervening atoms to form Ring D;Z2is CRZ2or N;RZ2is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci- C1-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 memberedWSGR Docket No. 70877-703.601heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Z3 is CRZ3or N;RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ3is taken together with one R3and the intervening atoms to form Ring E;Z4is CRZ4or N;RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ4is taken together with RUor RUNwith the intervening atoms to form Ring C;Ring B is 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, - S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7, or 8;Ring C is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more Rc;WSGR Docket No. 70877-703.601Ring D is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RD;Ring E is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RE;Ring F is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RF;provided that (i) at least one of Ring C, Ring D, Ring E and Ring F is present, or that two of RG1, RG2and RG3on adjacent atoms are taken together with the atoms to which they are attached to form a C6-C15aryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, and (ii) Ring C and Ring D are not both present;each of Rc, RD, RE, and RFis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, - OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C15cycloalkyl, C6-C15aryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two RC, two RD, and two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl;each Rais independently C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;WSGR Docket No. 70877-703.601or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-Csalkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci- Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, heterocycloalkyl, or C3- C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, C1-C3haloalkoxy, C1-C3hydroxyalkyl, C1-C3aminoalkyl, C1-C3heteroalkyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0050] In some embodiments, provided herein is a compound of Formula (I), or a pharmaceutically acceptable salt, or stereoisomer thereof:Formula (I),wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci- Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, CS- Cealkynyl, CNCi cycloalkyl. 4-15 membered heterocycloalkyl, C-C’i ar l. or 5-15 membered heteroaryl wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted; or two RG1or RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RG1is hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, - NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -WSGR Docket No. 70877-703.601C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C6-C15aryl, 5-15 membered heteroaryl, C5-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F;or two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted;each of RN1, RN2, and RN3is independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted; orone of RN1, RN2, and RN3and one of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the heteroaryl, or heterocycloalkyl is optionally substituted;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SFs, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csami noalky 1, C2-C4 alkenyl, C2-C4 alkynyl, Ci-Csheteroalkyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted; or one R2is taken together with a substituent of L1with the intervening atoms to form C,-C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted;n is 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRc-, -NRcSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- -NRcC(=O)O- -NRcC(=O)S- -NRcC(=S)O- -C(=O)NRc- -NRcC(=O)NRc- -NRcC(=S)NRc- -C(=S)NRc- -S(=O)2NRa-, -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-C6alkylene, Ci- Ceheteroalkylene, C2-Cealkenylene, C2-Cealkynylene, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -WSGR Docket No. 70877-703.601NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C6-C15aryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N- Ci-C3alkyl;X is N or C;Y is N or C;V is N, C, or CRV;W is N, NRWN, C, CRW, C(RW)2, -S-, or -O-;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two Rware taken together to form an oxo;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted;U is N, NRUN, CRU, C(RU)2, -S-, or -O-;each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two Ruare taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;WSGR Docket No. 70877-703.601RUNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted;Z1is CRZ1or N;RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), - N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, - C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, - C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci- C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci- C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C,-C’i aryl. Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted; or RZ1is taken together with RWor RWNwith the intervening atoms to form Ring D;Z2is CRZ2or N;RZ2is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted;Z3is CRZ3or N;RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted; or RZ3is taken together with one R3and the intervening atoms to form Ring E;Z4is CRZ4or N;WSGR Docket No. 70877-703.601RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted; or RZ4is taken together with RUor RUNwith the intervening atoms to form Ring C;Ring B is 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SFs, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, - S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted; or two R3on the same atom form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7, or 8;Ring C is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted;Ring D is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted;Ring E is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted;Ring F is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted;provided that (i) at least one of Ring C, Ring D, Ring E and Ring F is present, or that two of RG1, RG2and RG3on adjacent atoms are taken together with the atoms to which they are attached to form a C6-C15aryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, and (ii) Ring C and Ring D are not both present;each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-WSGR Docket No. 70877-703.601C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted;each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci- C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted;Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted;or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted; andReis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-Csalkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci- Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, heterocycloalkyl, or C3- Cecycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted.
[0051] In some embodiments, Ring E is present. In some embodiments, the compound of Formula (I) is of Formula (la):Formula (la)
[0052] In some embodiments, Ring C is present. In some embodiments, the compound of Formula (I) is of Formula (lb):Formula (lb)WSGR Docket No. 70877-703.601
[0053] In some embodiments, Ring D is present. In some embodiments, the compound of Formula (I) is of Formula (Ic):Formula (Ic)
[0054] In some embodiments, Ring F is present. In some embodiments, the compound of Formula (I) is of Formula (Id):Formula (Id)
[0055] In some embodiments, Ring E and Ring F are present. In some embodiments, the compound of Formula (I) is of Formula (le):Formula (le)
[0056] In some embodiments, the compound of Formula (le) is of Formula (Ie-1):Formula (Ie-1)WSGR Docket No. 70877-703.601
[0057] In some embodiments, the compound of Formula (le) is of Formula (Ie-2):Formula (Ie-2)
[0058] As used herein, a description of a Formula also includes a description of sub-formulas of such Formula. For example, a description of Formula (le) includes a description of sub-formulas of Formula (le), e.g., Formula (le- 1), Formula (Ie-2), etc.
[0059] In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is N, NRN1, CRG1, or C(RG1)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is NRN1. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is CRG1. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is C(RG1)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is N or CRG1.
[0060] In some embodiments of a compound of Formula (I) or (la)-(Ie), G2is N, NRN2, CRG2, or C(RG2)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), G2is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), G2is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), G2is NRN2. In some embodiments of a compound of Formula (I) or (la)-(Ie), G2is CRG2. In some embodiments of a compound of Formula (I) or (la)-(Ie), G2is C(RG2)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), G2is N or CRG2.
[0061] In some embodiments of a compound of Formula (I) or (la)-(Ie), Gs is N, NRN3, CRG3, or C(RG3)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gs is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gs is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gs is NRN3. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gs is CRG3. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gs is C(RG3)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), Gs is N or CRG3.
[0062] In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is CRG1, G2is CRG2, and Gs is CRG3.
[0063] In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is CRG1or C(RG1)2. In some embodiments, Gi is CRG1. In some embodiments, Gi is C(RG1)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG1is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, orWSGR Docket No. 70877-703.601heterocycloalkyl is optionally substituted with one or more R; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG1is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15aryl, 5-15 membered heteroaryl, C5-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-C1-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG1is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-C1-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG1is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C6-C15aryl, 5-15 membered heteroaryl, C5-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F.
[0064] In some embodiments of a compound of Formula (I) or (la)-(Ie), Gi is CRG1or C(RG1)2. In some embodiments, Gi is CRG1. In some embodiments, Gi is C(RG1)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG1is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -NRcRd, Ci-Cealkyl, or Ci-Cehaloalkyl, wherein the alkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG1is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -NRcRd, Ci-Cealkyl, or Ci-Cehaloalkyl, wherein the alkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG1is hydrogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG1is halogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG1is F. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG1is taken together with a substituent of L1with the intervening atoms to form Ring F.WSGR Docket No. 70877-703.601
[0065] In some embodiments of a compound of Formula (I) or (la)-(Ie), G2 is CRG2or C(RG2)2. In some embodiments, G2 is CRG2. In some embodiments, G2 is C(RG2)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG2is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciscycloalkyl, 4-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl, wherein the alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG2is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, C-Cisaryl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG2is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG2is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG2is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound ofWSGR Docket No. 70877-703.601Formula (I) or (la)-(Ie), each RG2is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG2is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG2is independently halogen, -CN, -OH, -ORa, -SF5, -NRcRd, Ci-Cealkyl, or Ci-Cehaloalkyl, wherein the alkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), each RG2is independently -SF5, Ci-Cehaloalkyl, or Cs-Ciscycloalkyl, wherein the cycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), each RG2is independently halogen, -CN, -OH, -ORa, -SF5, -NRcRd, Ci-Cealkyl, or Ci-Cehaloalkyl, wherein the alkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(le), RG2is Ci-Cehaloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG2is Ci-Ckhaloalk l. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG2is -CF3. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG2is -CHF2. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG2is -SF5. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG2is C3-C15 cycloalkyl, optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG2is C3-C6 cycloalkyl, optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG2is 4-15 membered heterocycloalkyl, optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), RG2is 4-6 membered heterocycloalkyl, optionally substituted with one or more R. In someembodiments of a compound of Formula (I) or (la)-(Ie), RG2is.
[0066] In some embodiments of a compound of Formula (I) or (la)-(Ie), G3 is CRG3or C(RG3)2. In some embodiments, G3 is CRG3. In some embodiments, G3 is C(RG3)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciscycloalkyl, 4-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl, wherein theWSGR Docket No. 70877-703.601alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments, Gs is C(RG3)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, G-C’i cycloalk l. or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG2on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(le), each RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -WSGR Docket No. 70877-703.601S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(le), each RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -NRcRd, Ci-Cealkyl, or Ci-Cehaloalkyl, wherein the alkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -NRcRd, Ci-Cealkyl, or Ci-Cehaloalkyl, wherein the alkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG3is hydrogen.
[0067] In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a C,-C’i aryl. C5-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a C,-C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl. In some embodiments, the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form 5-15 membered heterocycloalkyl, optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form 5-6 membered heterocycloalkyl, optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form dioxolane optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a C,-C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(le), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a phenyl, Ck-C, cycloalky L 5-6 membered heteroaryl, or 5-6 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form optionally substituted 5-15 membered heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form optionally substituted 5-6 membered heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to whichWSGR Docket No. 70877-703.601they are attached to form optionally substituted dioxolane. In some embodiments of a compound of Formula (I) or (la)-(Ie), two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form 2, 2-difluoro- 1,3 -dioxolane. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a phenyl, C5-Cecycloalkyl, 5-6 membered heteroaryl, or 5-6 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5- 15 membered heterocycloalkyl optionally substituted with one or more R. In some embodiments, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 6 membered heterocycloalkyl, which is optionally substituted with one or more R. In some embodiments, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5 membered heterocycloalkyl, which is optionally substituted with one or more R. In some embodiments, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to formF, wherein * indicates bonding to Gi and ** indicates bonding to Y.
[0068] In some embodiments of a compound of Formula (I) or (la)-(Ie), each of RN1, RN2, and RN3is independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl. In some embodiments, RN1is hydrogen, Ci-Cealkyl, or Ci-Cehaloalkyl. In some embodiments of a compound of Formula (I) or (la)-(le), each of RN1, RN2, and RN3is independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl. In some embodiments, RN1is hydrogen, Ci-Cealkyl, or Ci-Cehaloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments, RN2is hydrogen, Ci-Cealkyl, or Ci-Cehaloalkyl. In some embodiments, RN3is hydrogen, Ci-Cealkyl, or Ci-Cehaloalkyl.
[0069] In some embodiments of a compound of Formula (I) or (la)-(Ie), one of RN1, RN2, and RN3and one of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the heteroaryl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), one of RN1, RN2, and RN3and one of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the heteroaryl, or heterocycloalkyl is optionally substituted.WSGR Docket No. 70877-703.601
[0070] In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is Ce-Cisaryl, C3-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is C,-C’i ar l. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is phenyl. In some embodiments of a compound of Formula (I) or (la)-(le), Ring A is Cs-Ciscycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is Cs-Cecycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is 5-15 membered heteroaryl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is 5-6 membered heteroaryl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is 5 membered heteroaryl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is 6 membered heteroaryl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is pyridine. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is 4-15 membered heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring A is 4-6 membered heterocycloalkyl.
[0071] In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- -NRCC(=O)O- -NRCC(=O)S- -NRCC(=S)O- -C(=O)NRC- -NRCC(=O)NRC- -NRCC(=S)NRC- -C(=S)NRC- -S(=O)2NRa-, -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-_ -OP(=O)(ORa)NRb-, -OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-C6alkylene, Ci-Ceheteroalkylene, C2-C6alkenylene, C2-C6alkynylene, Ce-Ciearyl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- -NRcC(=O)O- -NRcC(=O)S- -NRcC(=S)O- -C(=O)NRC- -NRcC(=O)NRc- -NRcC(=S)NRc- -C(=S)NRC- -S(=O)2NRa-, -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-_ -OP(=O)(ORa)NRb-, -OP(=O)(NRaRb)O-, -NRcC(=NRc)-_ Ci-C6alkylene, Ci-C6heteroalkylene, C2-Cealkenylene, C2-Cealkynylene, Ce-Ciearyl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- -NRCC(=O)O- -NRCC(=O)S- -NRCC(=S)O- -C(=O)NRC- -NRCC(=O)NRC- -NRCC(=S)NRC- -C(=S)NRC- -S(=O)2NRa-, -S(=O)2-, -OP(=O)(ORa)NRb-, -OP(=O)(NRaRb)O-, -NRc(=NRc)-_ -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-Cealkylene, Ci-Ceheteroalkylene, C2-Cealkenylene, C2-C, alkynylene. Ce-Ciearyl, C3-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- -NRcC(=O)O- -NRcC(=O)S- -NRcC(=S)O- -C(=O)NRC- -NRcC(=O)NRc- -NRcC(=S)NRc- -C(=S)NRC- -S(=O)2NRa-, -S(=O)2-, -OP(=O)(ORa)NRb-, -OP(=O)(NRaRb)O-, -NRc(=NRc)-_ Ci-Cealkylene, Ci-Ccheteroalkylene, CS-Calkcnylcnc. C2-Cealkynylene, Ce-Ciearyl, Cs-Ciecycloalkyl, 5-15 membered heteroaryl, or 4-15 memberedWSGR Docket No. 70877-703.601heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is phenyl, C3-Cecycloalkyl, 5-6 membered heteroaryl, or 4-6 membered heterocycloalkyl, wherein the cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is 5-6 membered heteroaryl, which is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is 5 membered heteroaryl, which is optionally substituted with one or more R. In some embodiments of a compound ofFormula (I) or (la)-(Ie), L1is. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is -O-, -NRC-, -C(=O)O- -NRcC(=O)O- -C(=O)NRC- -NRcC(=O)NRc- Ci-C6alkylene, Ci-Ceheteroalkylene, C2-Cealkenylene, or C2-Cealkynylene, wherein the alkylene, heteroalkylene, alkenylene, or alkynylene is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is -C(=O)O- -NRcC(=O)O- -C(=O)NRC- or -NRcC(=O)NRc-. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is -C(=O)NRC-. In some embodiments, L1is -C(=O)NRC-, wherein the NRCis connected to Ring A. In some embodiments, L1is -C(=O)O-, wherein the -O- is connected to Ring A. In some embodiments, L1is -NRcC(=O)O-, wherein the -O- is connected to Ring A. In some embodiments, L1is -NRcC(=O)O-, wherein the NRCis connected to Ring A. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is absent. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is -C(=O)NH-. In some embodiments, L1is -C(=O)NH-, wherein the NH is connected to Ring A. In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is -C(=O)NRC- and Rcand RG1are taken together with the intervening atoms to form Ring F. In some embodiments, L1is -C(=O)NRC- and Rcand RG1are taken together to form a -CH2-CH2-, thereby forming Ring F (for example, see compound 164). In some embodiments, L1is -C(=O)NRC- and RcandRG1are taken together to form athereby forming Ring F (for example, see compound 215). In some embodiments of a compound of Formula (I) or (la)-(Ie), L1is P(=O)(Ra)- or -P(=O)(Ra)CH2-.
[0072] In some embodiments of a compound of Formula (I) or (la)-(Ie), each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-Cealkyl, Ci-Cealkoxy, Ci-Cehaloalkyl, Ci-Cehaloalkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, C2-C6 alkenyl, C2-C6 alkynyl, Ci-Ceheteroalkyl, Ce-CXaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted; or one R2is taken together with a substituent of L1with the intervening atoms to form C, -C’i aryl. Cs-CXcycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, orWSGR Docket No. 70877-703.601heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(le), each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Gaminoalk l. C2-C4 alkenyl, C2-C4 alkynyl, Ci-Csheteroalkyl, C-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or one R2is taken together with a substituent of L1with the intervening atoms to form Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl.-NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-Cdiydroxyalkyl. Ci-Csaminoalkyl, C2-C4 alkenyl, C2-C4 alkynyl, Ci-Cdictcroalkyl. C, -C’i aryl. C3-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted; or one R2is taken together with a substituent of L1with the intervening atoms to form C, -C’i aryl. C5-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl -NRcRd, or -P(=O)(Ci-C3alkyl)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R2is independently halogen, -CN, -S(=O)2Ci-C3alkyl, Ci-Csalkyl, Ci-Cshaloalkyl, or Ci-Csaminoalkyl, wherein alkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R2is independently halogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R2is independently -F. In some embodiments of a compound of Formula (I) or (la)-(Ie), R2is i -CN. In some NHembodiments of a compound of Formula (I) or (la)-(Ie), R2is. In some embodiments of a compound of Formula (I) or (la)-(Ie), R2is -S(=O)2CH3.
[0073] In some embodiments of a compound of Formula (I) or (la)-(Ie), n is 0, 1, 2, 3, 4, or 5. In some embodiments of a compound of Formula (I) or (la)-(Ie), n is 0, 1, or 2. In some embodiments of a compound of Formula (I) or (la)-(Ie), n is 0. In some embodiments of a compound of Formula (I) or (la)-(le), n is 1. In some embodiments of a compound of Formula (I) or (la)-(Ie), n is 2.
[0074] In some embodiments of a compound of Formula (I) or (la)-(Ie), R6is absent or L2-R22. In some embodiments of a compound of Formula (I) or (la)-(Ie), R6is absent. In some embodiments of a compound of Formula (I) or (la)-(Ie), R6is L2-R22.WSGR Docket No. 70877-703.601
[0075] In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- -NRCC(=O)O- -NRCC(=O)S- -NRCC(=S)O- -C(=O)NRC- -NRCC(=O)NRC- -NRCC(=S)NRC- -C(=S)NRC- -S(=O)2NRa-, -S(=O)2-,-S(=O)(=NRb)-, -N=S(=O)(Ra)-_ -OP(=O)(ORa)NRb-, -OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-C6alkylene, Ci-Ceheteroalkylene, C2-C6alkenylene, C2-C6alkynylene, C-C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- -NRcC(=O)O- -NRcC(=O)S- -NRcC(=S)O- -C(=O)NRC- -NRcC(=O)NRc- -NRcC(=S)NRc- -C(=S)NRC- -S(=O)2NRa-, -S(=O)2-,-S(=O)(=NRb)-, -N=S(=O)(Ra)-_ -OP(=O)(ORa)NRb-, -OP(=O)(NRaRb)O-, -NRcC(=NRc)-_ Ci-C6alkylene, Ci-C6heteroalkylene, C2-Cealkenylene, C2-C6alkynylene, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is absent, -NRC-, -C(=O)O- -NRCC(=O)O- -C(=O)NRC- -C(Re)=N-, or -NRCC(=O)NRC-. In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is absent or -C(=O)NRC-. In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is absent. In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is -C(=O)NRC-. In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is-C(=O)NH-. In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is -C(Re)=N-. In some embodiments of a compound of Formula (I) or (la)-(le), L2is -C(NH2)=N-. In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is -C(=O)O-. In some embodiments, L2is 5-15 membered heteroaryl or 4-15 membered heterocycloalkyl, each of which is optionally substituted with one or more R. In some embodiments, L2is 5-15 membered heteroaryl, each of which is optionally substituted with one or more R. In some embodiments, L2is 5-6 membered heteroaryl, each of which is optionally substituted with one or more R. In some embodiments, L2is 4-15 membered heterocycloalkyl, each of which is optionally substituted with one or more R. In some embodiments, L2is 5-6 membered heterocycloalkyl, each of which is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), L2is P(=O)(Ra)- or -P(=O)(Ra)CH2-.
[0076] In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C, -Ci aryl. or 5-15 membered heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -WSGR Docket No. 70877-703.601S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(le), R22is hydrogen, halogen, -CN, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, C3-Ciocycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cioaryl, or 5-10 membered heteroaryl; wherein the cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22is independently halogen, -CN, -S(=O)2Ci-C3alkyl, Ci-C3alkyl, Ci-C3haloalkyl, or Ci-C3aminoalkyl, wherein alkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), R22is hydrogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is hydrogen, -CN, -ORa, -NRcRd, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, C3-Ci5cycloalkyl, 5-15 membered heterocycloalkyl, or 5-15 membered heteroaryl; wherein each cycloalkyl, heterocycloalkyl, and heteroaryl is independently optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is hydrogen, halogen, -C(=O)NRcRd, 5-15 membered heterocycloalkyl, or 5-15 membered heteroaryl; where the heterocycloalkyl, heteroaryl is optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is hydrogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is -C(=O)NRcRd. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is -CN. In some embodiments of aNHcompound of Formula (I) or (la)-(Ie), R22is. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is -S(=O)2CH3. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 5-15 membered heterocycloalkyl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 5-15 membered heteroaryl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 5-6 membered heteroaryl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 5 membered heteroaryl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 5-6 membered heterocycloalkyl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 5 membered heterocycloalkyl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 8 membered heterocycloalkyl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is C3-Ciocycloalkyl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(le), R22is C3-C,, cycloalkyl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is cyclopropyl, optionally substituted with one or more R22a. InWSGR Docket No. 70877-703.601some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 9 membered heterocycloalkyl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)- (le), R22is 5 membered heteroaryl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 9-10 membered heteroaryl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 9 membered heteroaryl optionally substituted with one or more R22a. In some embodiments of a compound of Formula(I) or (la)-(Ie), R22is bicyclic heteroaryl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is 5-6, 6-5, or 5-5 bicyclic heteroaryl optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(le), R22is 5-6 fused bicyclic heteroaryl (e.g.,optionally substituted with one or more R22a. Insome embodiments of a compound of Formula (I) or (la)-(Ie), R22isIn some embodimentsof a compound of Formula (some embodiments of a compound ofFormula (, which is optionally substituted with one or more R22a. Insome embodiments of a compound of Formula (, which is optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is-C(O)NH2. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is -CN. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is -N(CH3)2. In some embodiments of acompound of Formula (I) or (la)-(Ie), R22is, which is optionally substituted with one or moreHN^\T 'NR22a.. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is ', which is optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) orwhich is optionally substituted with one or more R22a. In someN-NHembodiments of a compound of Formula (I) or (la)-(Ie), R22is, which is optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22isWSGR Docket No. 70877-703.601, which is optionally substituted with one or more R22a. In some embodiments of a compoundof Formula (I) or (la)-(Ie), R22is 'N, which is optionally substituted with one or more R22a. In someembodiments of a compound of Formula (I) or (la)-(Ie), R22is, which is optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22iso, which is optionally substituted with one or more R22a. In some embodiments of aHcompound of Formula (I) or (la)-(Ie), R22is. which is optionally substituted with one or moreHR22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is, which is optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or(la)-(Ie), R22is, which is optionally substituted with one or more R22a. In some embodimentsHof a compound of Formula (I) or (la)-(Ie), R22is, which is optionally substituted with one ormore R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is. In some,HFormula (I) or (la)-(Ie), R22is HNXX, which is optionally substituted with one or more R22a. InN=Nsome embodiments of a compound of Formula (I) or (la)-(Ie), R22is, which is optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22is o, which is optionally substituted with one or more R22a. In some embodiments of a compound ofWSGR Docket No. 70877-703.601Formula (I) or (la)-(Ie), R22is, which is optionally substituted with one or more R22a. In someembodiments of a compound of Formula (I) or (la)-(Ie), R22is, which is optionally substitutedwith one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22iswhich is optionally substituted with one or more R22a. In some embodiments of a compound of Formula, which is optionally substituted with one or more R22a. In someembodiments of a compound of Formula (I) or (la)-(Ie), R22is, which is optionally substituted with one or more R22a. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22isI IIn some embodiments of a compound of Formula (I) or (la)-(Ie), R22is
[0077] In some embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments, each of L1and L2is independently -C(=O)NRC- or absent. In some embodiments, each ofL1and L2is independently -C(=O)NRC-, and Rcand RG1are taken together with the intervening atoms to form Ring F. In some embodiments, each of L1and L2is -C(=O)NH-. In some embodiments of acompound of Formula (WSGR Docket No. 70877-703.601some embodiments of a compound of Formula (
[0078] In some embodiments of a compound of Formula (some embodiments of a compound of Formula (I) or (la)-(Ie),absent. In some embodiments, each of L1and L2is independently -C(=O)NRC-. In some embodiments, each of L1and L2is -C(=O)NH-. In some embodiments of a compound of Formula (I) or (la)-(Ie),
[0079] In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C -Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo,WSGR Docket No. 70877-703.601=NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C-C’i ar l. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C, -Ci aryl. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl.
[0080] In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-WSGR Docket No. 70877-703.601Ceheteroalkyl, C2-C, alkenyl. CS-C.alkynyl. Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C-C-isaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais -CN, -ORa, Ci-Cealkyl, Ci-Cehaloalkyl, or Cs-Ciscycloalkyl, wherein each alkyl and cycloalkyl, is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais -CN. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais Cs-Cecycloalkyl, which is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), R22ais, which is optionally substituted with one or more R. In some embodiments of acompound of Formula (I) or (la)-(Ie), R22ais. In some embodiments of a compound of Formula (I)XLCNor (la)-(Ie), R22ais. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais methyl (e.g., CDs). In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais methyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais CDs. In some embodiments of acompound of Formula (I) or (la)-(Ie), R22ais. In some embodiments of a compound of Formula (I)IF °F— I or (la)-(Ie), R22ais. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais 'IIn some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais -OCHs (e.g., -OCDs). In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais -OCHs. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais -OCDs.
[0081] In some embodiments of a compound of Formula (I) or (la)-(Ie), two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-Csalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), two R22aon the same atom are taken together to form an oxo.
[0082] In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais independently halogen, -CN, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6alkoxy, or C3-Ciocycloalkyl, wherein each alkyl or cycloalkyl is independently optionally substituted with one or more R, or two R22aon the same atom form an oxo. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R22ais independently halogen, Ci-Cealkyl, Ci-Cealkoxy, or Cs-Ciscycloalkyl, wherein the alkyl or cycloalkyl is each optionally substituted with one or more R, or two R22aon the same atom form an oxo. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais halogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais Ci-Cealkyl optionally substituted with oneWSGR Docket No. 70877-703.601or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais Ci-Ce alkoxy. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais C3-C15 cycloalkyl optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), R22ais optionally substituted C3-C15 cycloalkyl.
[0083] In some embodiments of a compound of Formula (I) or (la)-(Ie), X is N or C. In some embodiments of a compound of Formula (I) or (la)-(Ie), X is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), X is C.
[0084] In some embodiments of a compound of Formula (I) or (la)-(Ie), Y is N or C. In some embodiments of a compound of Formula (I) or (la)-(Ie), Y is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), Y is C.
[0085] In some embodiments of a compound of Formula (I) or (la)-(Ie), V is N or C. In some embodiments of a compound of Formula (I) or (la)-(Ie), V is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), V is C. In some embodiments of a compound of Formula (I) or (la)-(Ie), V is CRV. In some embodiments of a compound of Formula (I) or (la)-(Ie), V is C-OH.
[0086] In some embodiments of a compound of Formula (I) or (la)-(Ie), Rvis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rvis independently hydrogen, halogen, -CN, -OH, -ORa, Ci-Cealkyl, or Ci-Cehaloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rvis -OH.
[0087] In some embodiments of a compound of Formula (I) or (la)-(Ie), W is N, NRWN, C, CRW, C(RW)2, -S-, or -O-. In some embodiments of a compound of Formula (I) or (la)-(Ie), W is NRWN, CRW, or -S-. In some embodiments of a compound of Formula (I) or (la)-(Ie), W is NRWNor -S-. In some embodiments of a compound of Formula (I) or (la)-(Ie), W is NRWN. In some embodiments of a compound of Formula (I) or (la)-(Ie), W is -S-. In some embodiments of a compound of Formula (I) or (la)-(Ie), W is -O-. In some embodiments of a compound of Formula (I) or (la)-(Ie), W is CRW.
[0088] In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, CS-Cealkenyl, C2-Cealkynyl, Ce-Cis aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 memberedWSGR Docket No. 70877-703.601heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rwis independently hydrogen, Ci-Cealkyl, or Cs-Ciscycloalkyl, wherein the alkyl or cycloalkyl is optionally substituted with two or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rwis Ci-Cealkyl optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), Rwis -CH2CH3. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -0Ra, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two Rware taken together to form an oxo. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rwis hydrogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rwis Ci-Cealkyl, optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rwis G-C’i cycloalkyl. optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rwis halogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rwis F. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rwis ethyl.
[0089] In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis -CN, -C(=0)Ra, -C(=0)0Rb, -C(=0)NRcRd, Ci-Cealkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), R'™ is -CN, -C(=0)Ra, -C(=0)0Rb, -C(=0)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C, -Ci aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis -CN, -C(=0)Ra, -C(=0)0Rb, -C(=0)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), R'™ is -CN, -C(=0)Ra, -C(=0)0Rb, -C(=0)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Ceheteroalkyl, C3-C10 cycloalkyl, or 4-10 membered heterocycloalkyl, wherein the alkyl, heteroalkyl,WSGR Docket No. 70877-703.601alkoxy, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Ceheteroalkyl, C3-C, cycloalkyl, or 4-6 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis C3-C, cycloalkyl, which is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), R'™ is 4-6 membered heterocycloalkyl, which is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis Ci-Cealkyl or Ci-Ceheteroalkyl, wherein the alkyl or heteroalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis C3-C10 cycloalkyl optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis C3-C, cycloalkyl optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis cyclopropyl, optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis Ci-Cealkyl optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis -CH2CH3. In some embodiments, the -CH2CH3 is -CD2CD3In some embodiments of a compound of Formula (I) or (la)-(Ie), RWNis. In some embodiments ofa compound of Formula (
[0090] In some embodiments of a compound of Formula (I) or (la)-(Ie), U is N, NRUN, CRU, C(RU)2, -S-, or -O-. In some embodiments of a compound of Formula (I) or (la)-(Ie), U is N, NR' -S-, or CRU. In some embodiments of a compound of Formula (I) or (la)-(Ie), U is N, -S-, or CRU. In some embodiments of a compound of Formula (I) or (la)-(Ie), U is N. In some embodiments of a compound of Formula (I) or (la)-(Ie), U is -S-. In some embodiments of a compound of Formula (I) or (la)-(Ie), U is CRU. In some embodiments of a compound of Formula (I) or (la)-(Ie), U is C(RU)2. In some embodiments of a compound of Formula (I) or (la)-(Ie), U is -S-. In some embodiments of a compound of Formula (I) or (la)-(Ie), U is NR'-\
[0091] In some embodiments of a compound of Formula (I) or (la)-(Ie), each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Ruare taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C,-Ci s aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl,WSGR Docket No. 70877-703.601cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Ruare taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two Ruare taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Ruis independently hydrogen, halogen, Ci-Cealkyl, or C3-C15 cycloalkyl, wherein the alkyl or cycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Ruis independently hydrogen or Ci-Cealkyl, wherein the alkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ruis hydrogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ruis Ci-Cealkyl optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ruis -CH2CH3. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ruis F. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ruis Cs-Ciscycloalkyl optionally substituted with one or more R.
[0092] In some embodiments of a compound of Formula (I) or (la)-(Ie), ™ is -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-Cealkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), RUNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C, -Ci aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), ™ is -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), RUNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), ™ is Ci-Cealkyl or C3-C15 cycloalkyl, wherein the alkyl or cycloalkyl is optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), ™ is Ci-Cealkyl optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), ™ is C3-C15 cycloalkyl optionally substituted with one or more R.WSGR Docket No. 70877-703.601In some embodiments of a compound of Formula (I) or (la)-(Ie), R™ is C3-C„ cycloalkyl optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), R™ isethyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), R™ is.
[0093] In some embodiments of a compound of Formula (I) or (la)-(Ie), Z1is CRZ1or N. In some embodiments of a compound of Formula (I) or (la)-(Ie), Zi is CRZ1. In some embodiments of a compound of Formula (I) or (la)-(Ie), Zi is N.
[0094] In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C,-C’i saryl. C3-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted (e.g., with one or more R). In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted (e.g., with one or more R). In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ1is taken together with Rwor R'™ with the intervening atoms to form Ring D. In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, or Ci-C3heteroalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ1is hydrogen. In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ1is F.
[0095] In some embodiments of a compound of Formula (I) or (la)-(Ie), Z2is CRZ2or N. In some embodiments of a compound of Formula (I) or (la)-(Ie), Z2is CRZ2. In some embodiments of a compound of Formula (I) or (la)-(Ie), Z2is N.
[0096] In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ2is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -WSGR Docket No. 70877-703.601S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C, -C’i aryl. C3-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted (e.g., with one or more R). In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ2is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C, -C’i aryl. C3-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted (e.g., with one or more R). In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ2is hydrogen, halogen, -CN, -OH, -SH, -SFs, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, or Ci-C3heteroalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ2is hydrogen.
[0097] In some embodiments of a compound of Formula (I) or (la)-(Ie), Z3is CRZ3or N. In some embodiments of a compound of Formula (I) or (la)-(Ie), Z3is CRZ3. In some embodiments of a compound of Formula (I) or (la)-(Ie), Z3is N.
[0098] In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C, -C’i aryl. C3-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted (e.g., with one or more R). In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -WSGR Docket No. 70877-703.601C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C, -C’i aryl. C3-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted (e.g., with one or more R). In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ3is taken together with one R3and the intervening atoms to form Ring E. In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, or Ci-C3heteroalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ3is hydrogen.
[0099] In some embodiments of a compound of Formula (I) or (la)-(Ie), Z4 is CRZ4or N. In some embodiments of a compound of Formula (I) or (la)-(Ie), Z4 is CRZ4. In some embodiments of a compound of Formula (I) or (la)-(Ie), Z4 is N.
[0100] In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci-C3alkyl)2.-NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHC1-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C, -C’i aryl. C3-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted (e.g., with one or more R). In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci-C3alkyl)2.-NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHC1-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C, -C’i aryl. C3-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted (e.g., with one or more R). In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ4is taken together with Ruor ™ with the intervening atoms to form Ring C. In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ4is taken together with R™ with the intervening atoms to form Ring C. In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -WSGR Docket No. 70877-703.601C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, or Ci-C3heteroalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), RZ4is hydrogen.
[0101] In some embodiments of a compound of Formula (I) or (la)-(Ie), Zi is CRZ1, Z2is CRZ2, Z3is CRZ3, and Z4is CRZ4
[0102] In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring C is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more Rc. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring C is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring C is absent. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring C is 5-15 membered heterocycloalkyl optionally substituted with one or more Rc. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring C is 7-membered heterocycloalkyl optionally substituted with one or more Rc. In some embodiments, two Rcon the same atom are taken together to form an oxo. Insome embodiments of a compound of Formula (has a structure ofwherein each * indicates bonding to Z3.
[0103] In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring D is absent, C,-C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RD. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring D is absent, C -C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring D is absent. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring D is 5-15 membered heterocycloalkyl optionally substituted with one or more RD. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring D is 7-membered heterocycloalkyl optionally substituted with one or more RD. In some embodiments, two RDon the same atom are taken together to form an oxo.
[0104] In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RE. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is absent, C -C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted. In some embodiments of a compound of Formula (I) orWSGR Docket No. 70877-703.601(la)-(Ie), Ring E is absent. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is monocyclic. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is bicyclic. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is tricyclic. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is polycyclic.. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is spiro bicyclic. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is a bicyclic ring that comprises a spirocyclic heterocycloalkyl or cycloalkyl (e.g., cyclopropyl). In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is a bicyclic ring that comprises a 6-9 membered heterocycloalkyl and a spirocyclic C3-C3cycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is a bicyclic ring that comprises a 7 membered heterocycloalkyl and a spirocyclic C3-C3cycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is 5-15 membered heterocycloalkyl optionally substituted with one or more RE. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is 7-membered heterocycloalkyl optionally substituted with one or more RE. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is 8-membered heterocycloalkyl optionally substituted with one or more RE. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is 9-membered heterocycloalkyl optionally substituted with one or more RE. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is 10-membered heterocycloalkyl optionally substituted with one or more RE. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is a bicyclic heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is a spirocyclic heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is a bicyclic cycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is a spirocyclic heterocycloalkyl. In some embodiments, Ring E comprises 0-1 ring oxygen atom and 1-2 ring nitrogen atoms. In some embodiments, two REon the same atom are taken together to form an oxo. In somehas a structure of. In some embodiments of a compound of Formula (I) or (la)-(Ie),some embodiments of a compound of FormulaWSGR Docket No. 70877-703.601some embodiments of a compound of Formula (embodiments of a compound of Formula (In some embodiments of a compound of Formula (Formula (some embodimentsIn some embodiments of a compound of Formula (WSGR Docket No. 70877-703.601In some embodiments, p is 0. In some embodiments, p is 1. In some embodiments, p is 2. In some embodiments, p is 3. In some embodiments of a compound of Formula (I) or (la)-(Ie),,some embodiments of a compound of Formula (I)WSGR Docket No. 70877-703.601compound of Formula (some embodiments of a compoundstructure ofIn some embodiments of a compound of Formula (I) or (la)-(Ie),WSGR Docket No. 70877-703.601
[0105] In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RF. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring E is absent, C -C’i aryl. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring F is absent. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring F is 5-15 membered heterocycloalkyl optionally substituted with one or more RF. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring F is 6-membered heterocycloalkyl optionally substituted with one or more RF. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring F is 7-membered heterocycloalkyl optionally substituted with one or more RF. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring F is 8-membered heterocycloalkyl optionally substituted with one or more RF. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring F is monocyclic, bicyclic, or polycyclic. In some embodiments, ring F is bicyclic. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring F is spiro bicyclic. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring F is fused bicyclic. In some embodiments, two RFon the same atom are taken together to form an oxo.WSGR Docket No. 70877-703.601embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments of a compound of Formula (WSGR Docket No. 70877-703.601embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments of a compound of Formula (embodiments of a compound of Formula (WSGR Docket No. 70877-703.601embodiments of a compound of Formula (some embodiments of a compound of Formula (some embodiments of a compound of Formula (embodiments of a compound of Formula (some embodiments of a compound of Formula (some embodiments of a compound of Formula (. In some embodiments of a compound of Formula (I) or (la)-(Ie),WSGR Docket No. 70877-703.601ulacompound of Formula (WSGR Docket No. 70877-703.601
[0107] In some embodiments of a compound of Formula (
[0108] In some embodiments of a compound of Formula (ula (I) or (Id)WSGR Docket No. 70877-703.601rmula (I) orWSGR Docket No. 70877-703.601some embodiments of a compound of
[0109] In some embodiments of a compound of FormulaWSGR Docket No. 70877-703.601Formulasome embodiments of a compound of Formulasome embodiments of a compound of Formulasome embodiments of a compound of FormulasomeWSGR Docket No. 70877-703.601embodiments of a compound of Formulasome embodiments of a compound of FormulaIn some embodiments of a compound of FormulaIn some embodiments of a compound of Formula (la) or (le),
[0110] In some embodiments of a compound of FormulaWSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601embodiments of a compound of Formulasome embodiments of a compound of Formulasome embodiments of a compound of Formulasome embodiments of a compound of FormulaIn some embodiments of a compound of FormulaWSGR Docket No. 70877-703.601some embodiments of a compound of Formula (la) or (le),
[0113] In some embodiments, provided herein is a compound of Formula (le), or a pharmaceutically acceptable salt thereof, wherein,provided herein is a compound of Formula (le), or a pharmaceutically acceptable salt thereof,WSGR Docket No. 70877-703.601embodiments, R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciocycloalkyl, 5-15 membered heterocycloalkyl, C, -C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a. In some embodiments, R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ciocycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i ar l. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a. In some embodiments, each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl,-NRcRd, or -P(=O)(Ci-C3alkyl)2. In some embodiments,some embodiments of a compound of Formula (I) or (la)-(Ie), L2is absent or-C(=O)NH-. In some embodiments, R22is 5-6, 6-5, or 5-5 bicyclic heteroaryl optionally substituted with one or more R22a. In some embodiments, R22is 5 or 6 membered heteroaryl optionally substituted with one or more R22a.
[0114] In some embodiments of a compound of Formula (I) or (la)-(Ie), (i) at least one of Ring C, Ring D, Ring E and Ring F is present, or that two of RG1, RG2and RG3on adjacent atoms are taken together with the atoms to which they are attached to form a C,-C’i ar l. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, and (ii) Ring C and Ring D are not both present. In some embodiments of a compound of Formula (I) or (la)-(Ie), (i) at least one of Ring C, Ring D, Ring E and Ring F is present, or that two of RG1, R '2and RG3on adjacent atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15WSGR Docket No. 70877-703.601membered heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring C and Ring D are not both present.
[0115] In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring B is 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring B is 5-15 membered heteroaryl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring B is 4-15 membered heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring B is a 5-membered heteroaryl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring B is a 5 -membered heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring B is a triazole. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring ok / L 'N[ L—KN N i N^\B is. In some embodiments of a compound of Formula (I) or (la)-(Ie), Ring B is H. Insome embodiments of a compound of Formula (some embodiments of a compound of Formula (I) or (la)-(Ie), Ring B is a bicyclic heterocycloalkyl. Insome embodiments of a compound of Formula (I) or (la)-(Ie),
[0116] In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 0, 1, 2, 3, 4, 5, or 6. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 0, 1, 2, 3, 4, 5, 6, 7, or 8. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 0, 1, 2, 3, or 4. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 1, 2, or 3. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 0. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 1. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 2. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 3. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 4. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 5. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 6. In some embodiments of a compound of Formula (I) or (la)-(le), p is 7. In some embodiments of a compound of Formula (I) or (la)-(Ie), p is 8.
[0117] In some embodiments of a compound of Formula (I) or (la)-(Ie), each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2,Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -WSGR Docket No. 70877-703.601OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-C6aminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl and heterocycloalkyl are optionally substituted; or two R3on the same atom form an oxo, thioxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R3is independently halogen, -CN, -OH, -ORa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, or two R3on the same atom form an oxo. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R3is independently Ci-Cealkyl or two R3on the same atom form an oxo. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R3is methyl.
[0118] In some embodiments of a compound of Formula (I) or (la)-(Ie), each of Rc, RD, RE, and RFis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, C,-C’i aryl. 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two RC, two RD, and two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each of Rc, RD, RE, and RFis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, C„-Cisaryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted or two RC, two RD, and two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0119] In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rcis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -WSGR Docket No. 70877-703.601C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, C,-C’i aryl. 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two Rcon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0120] In some embodiments of a compound of Formula (I) or (la)-(Ie), each RDis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, C,-C’i aryl. 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two RDon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RDis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, Ce-Cisaryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted R; or two RDon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), RDis -halogen, -CN, -OH, -ORa, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, G-C, cycloalkyl. or 4-6 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl are optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), RDis -halogen, Ci-Cealkyl, or Ci-Cehaloalkyl.
[0121] In some embodiments of a compound of Formula (I) or (la)-(Ie), each REis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, C,-C’i aryl. 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each REis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -WSGR Docket No. 70877-703.601C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, Ce-Cisaryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted; or two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), REis -halogen, -CN, -OH, -ORa, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, Cs-Cecycloalkyl, or 4-6 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl are optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), REis -halogen, Ci-Cealkyl, or Ci-Cehaloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), REis methyl.
[0122] In some embodiments of a compound of Formula (I) or (la)-(Ie), each RFis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, C,-C’i aryl. 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two RFon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each RFis independently -halogen, -CN, -OH, -ORa, -SFs, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, Ce-Cisaryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted; or two RFon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), RFis -halogen, -CN, -OH, -ORa, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, G-C, cycloalkyl. or 4-6 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl are optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), RFis -halogen, Ci-Cealkyl, or Ci-Cehaloalkyl.
[0123] In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionallyWSGR Docket No. 70877-703.601substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-Cealkylene (heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Ceheteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl, wherein each alkyl, alkylene, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Ceheteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl, wherein each alkyl, heteroalkyl, alkylene, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R.
[0124] In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl,WSGR Docket No. 70877-703.601alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, or Ci-Ceheteroalkyl, wherein each alkyl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, or Ci-Ceheteroalkyl, wherein each alkyl and heteroalkyl is independently optionally substituted with one or more R.
[0125] In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-Cealkylene (heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-C6alkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted.
[0126] In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl,WSGR Docket No. 70877-703.601alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), Rcis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, wherein each alkyl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, wherein each alkyl and heteroalky is independently optionally substituted with one or more R.
[0127] In some embodiments of a compound of Formula (I) or (la)-(Ie), Rdis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rdis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(le), Rdis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rdis hydrogen, Ci-Cealkyl,WSGR Docket No. 70877-703.601Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rdis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, wherein each alkyl is independently optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rdis hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, wherein each alkyl and heteroalkyl is independently optionally substituted with one or more R.
[0128] In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R. In some embodiments of a compound of Formula (I) or (la)-(Ie), Rcand Rdare taken together with the atom to which they are attached to form an optionally substituted heterocycloalkyl.
[0129] In some embodiments of a compound of Formula (I) or (la)-(Ie), Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-Csalkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, heterocycloalkyl, or Cs-Cecycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-C3alkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, heterocycloalkyl, or C3-C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted. In some embodiments of a compound of Formula (I) or (la)-(Ie), Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-C3alkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-C3aminoalkyl, Ci-Csheteroalkyl, heterocycloalkyl, or C3-C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R. In some embodiments, the heterocycloalkyl is 3-15 membered heterocycloalkyl. In some embodiments, the heterocycloalkyl is 5-6 membered heterocycloalkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), Reis -NH2. In some embodiments of a compound of Formula (I) or (la)-(Ie), Reis Ci-C3alkyl.
[0130] In some embodiments of a compound of Formula (I) or (la)-(Ie), each R is independently halogen, -CN, (Ci-C6alkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHC1-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-Cshydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, or C3-C15cycloalkyl; or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R is independently halogen, -CN, -OH, -SF5, -SH, -NH2, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, -C(=O)OH, -C(=O)NH2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl,WSGR Docket No. 70877-703.601Ci-C3aminoalkyl, Ci-C3heteroalkyl, or Cs-Ciscycloalkyl; or two R on the same atom form an oxo. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R is independently -CN or C3-Ciscycloalkyl; or two R on the same atom form an oxo. In some embodiments, R is Ci-C3alkyl. In some embodiments, R is Ci-C3alkoxy. In some embodiments, R is Ci-C3haloalkyl. In some embodiments, R is Ci-Cshaloalkoxy.
[0131] In some embodiments of a compound of Formula (I) or (la)-(Ie), each R is independently halogen, -CN, (Ci-C6alkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHC1-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C3-Ci5cycloalkyl, 4-15 membered heterocycloalkyl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl. In some embodiments of a compound of Formula (I) or (la)-(Ie), each R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci-C3heteroalkyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-Ci5cycloalkyl, 4-15 membered heterocycloalkyl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0132] In some embodiments of a compound of Formula (I) or (la)-(Ie), the compound is a compound of Table 1.TABLE 1WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601WSGR Docket No. 70877-703.601
[0133] Disclosed herein is a compound of Formula (II), or a pharmaceutically acceptable salt, or stereoisomer thereof:wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG1, RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, - S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci- Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a C,-C’i aryl. C5- Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or twoWSGR Docket No. 70877-703.601RG1, RG2or RG3, on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-Csalkyl;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, C2-C4alkenyl, C2-C4alkynyl, Ci-Csheteroalkyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is an integer from 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O-, -NRCC(=O)O- -NRCC(=O)S- -NRCC(=S)O- -S(=O)2-,-S(=O)(=NRb)-, -N=S(=O)(Ra)-, -C(=O)NRC-, -NRCC(=O)NRC- -NRCC(=S)NRC- -C(=S)NRC- -S(=O)2NRa-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-C6alkylene, Ci- Ceheteroalkylene, C2-Cealkenylene, C2-Cealkynylene, Ce-Cioaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciocycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl,WSGR Docket No. 70877-703.601alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;a single bond or a double bond;Ring G is a 5 membered heterocycloalkyl or 5-6 membered heteroaryl comprising ring members Y, X, W, and V;X and Y are each independently C or N;V is CH, C, orN;W is C, CRW, C(RW)2, N, NRWN, -S-, or -O-;wherein, when (i) W is NRWNand ring G is a pyrrole, or (ii) W is NRWN, X is C, Y is C, and ring G is an imidazole, then the 6-membered ring comprising G1, G2, G3, X and Y is a pyridone;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SH, -SRa, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Ci-C6alkyl-C3-Cecycloalkyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;each R5is independently Ci-Csalkyl, Ci-Csalkoxy, C1-C3haloalkyl, C1-C3haloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, or C 1 -Cdictcroalkyl: or two R5are taken together to form an oxo;q is 0, 1, or 2;L3is C1-C6alkynylene, C6-C10aryl, C3-C10heteroaryl, C4-C10heterocycloalkyl, or C3-C10cycloalkyl, wherein the aryl, heteroaryl, heterocycloalkyl, or cycloalkyl is optionally substituted with one or more R;Ring B is 5-15 membered heteroaryl or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7, or 8;WSGR Docket No. 70877-703.601each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci- C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci- C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-C6alkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, or C3-C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2C1-C3alkyl, -S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)2N(C1-C3alkyl)2, -S(=O)(=NC1-C3alkyl)(C1-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci- Csheteroalkyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, (Ci-C3alkyl)-(C3- Ciscycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0134] In some embodiments, provided herein is a compound of Formula (II), or a pharmaceutically acceptable salt, or stereoisomer thereof:WSGR Docket No. 70877-703.601Formula (II),wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG1, RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, - S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci- Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted; or two RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted; or two RG1, RG2or RG3, on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, C1-C3aminoalkyl, C2-C4alkenyl, C2-C4alkynyl, C1-C3heteroalkyl, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted;n is an integer from 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-_ -C(=O)O- - NRcC(=O)O- -NRcC(=O)S- -NRcC(=S)O- -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-, -WSGR Docket No. 70877-703.601C(=O)NRC- -NRCC(=O)NRC- -NRCC(=S)NRC- -C(=S)NRC- -S(=O)2NRa-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-C6alkylene, Ci- Ceheteroalkylene, C2-Cealkenylene, C2-Cealkynylene, Ce-Cioaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted; R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciocycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N- Ci-C3alkyl;a single bond or a double bond;Ring G is a 5 membered heterocycloalkyl or 5-6 membered heteroaryl comprising ring members Y, X, W, and V;X and Y are each independently C or N;V is CH, C, orN;W is C, CRW, C(RW)2, N, NRWN, -S-, or -O-;wherein, when (i) W is NRWNand ring G is a pyrrole, or (ii) W is NRWN, X is C, Y is C, and ring G is an imidazole, then the 6-membered ring comprising G1, G2, G3, X and Y is a pyridone;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SH, -SRa, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted; or two Rware taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Ci-C.alkyl-C’s-WSGR Docket No. 70877-703.601Cecycloalkyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted; each R5is independently Ci-Csalkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, or Ci-Csheteroalkyl; or two R5are taken together to form an oxo;q is 0, 1, or 2;L3is C1-C6alkynylene, C6-C10aryl, C3-C10heteroaryl, C4-C10heterocycloalkyl, or C3-C10cycloalkyl, wherein the aryl, heteroaryl, heterocycloalkyl, or cycloalkyl is optionally substituted with one or more R;Ring B is 5-15 membered heteroaryl or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, - S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl and heterocycloalkyl are optionally substituted; or two R3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7 or 8;each Rais independently C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted;each Rbis independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted;Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted; or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted;Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-C6alkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, or C3-C6cycloalkyl,WSGR Docket No. 70877-703.601wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci- C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci- C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalky 1, or C3-Cecycloalkyl; or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0135] In some embodiments, the compound of Formula (II) is of Formula (Ila):
[0136] In some embodiments of Formula (II) or (Ila), Ring G is a five membered ring comprising ring members X, Y, W, V, and U.
[0137] In some embodiments, the compound of Formula (II) is of Formula (lib):wherein,U is N, NR5, NH, CR5, CH, CH2, CHR5, C(R5)2, -S-, or -O-.
[0138] In some embodiments, the compound of Formula (II) is of Formula (lib):wherein,WSGR Docket No. 70877-703.601U is N, NR5, CR5, C(R5)2, -S-, or -0-.
[0139] In some embodiments, the compound of Formula (II) is of Formula (lib):wherein,G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG1, RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, - S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci- Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce- saryl, C5- Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or two RG' RG2or RG3, on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci- Galkyl;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, C1-C3aminoalkyl, C2-C4alkenyl, C2-C4alkynyl, C1-C3heteroalkyl, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is an integer from 0, 1, 2, 3, 4, or 5;WSGR Docket No. 70877-703.601R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRc-, -NRcSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O-, -NRCC(=O)O- -NRCC(=O)S- -NRCC(=S)O- -S(=O)2-,-S(=O)(=NRb)-, -N=S(=O)(Ra)-, -C(=O)NRC-, -NRCC(=O)NRC- -NRCC(=S)NRC- -C(=S)NRC- -S(=O)2NRa-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-C6alkylene, Ci- Ceheteroalkylene, C2-Cealkenylene, C2-Cealkynylene, Ce-Cioaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciocycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;' ' is a single bond or a double bond;Ring G is a 5 membered heterocycloalkyl or 5-6 membered heteroaryl comprising ring members Y, X, W, and V;X and Y are each independently C or N;U is N, NR5, NH, CR5, CH, CH2, CHR5, C(R5)2, -S-, or -O-;V is CH, C, orN;W is C, CRW, C(RW)2, N, NRWN, -S-, or -O-;wherein, when (i) W is NRWNand ring G is a pyrrole, or (ii) W is NRWN, X is C, Y is C, and ring G is an imidazole, then the 6-membered ring comprising Gi, G2, Gs, X and Y is a pyridone;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SH, -SRa, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-C6alkenyl, C2-Cealkynyl, C3-C15WSGR Docket No. 70877-703.601cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Ci-C.alkyl-C’s- Cecycloalkyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;each R5is independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci- Cdialoalkoxy. Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, or Ci-Csheteroalkyl; or two R5are taken together to form an oxo;q is 0, 1, or 2;L3is C1-C6alkynylene, C6-C10aryl, C3-C10heteroaryl, C4-C10heterocycloalkyl, or C3-C10cycloalkyl, wherein the aryl, heteroaryl, heterocycloalkyl, or cycloalkyl is optionally substituted with one or more R;Ring B is 5-15 membered heteroaryl or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, - S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7, or 8;each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci- C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci- C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl,WSGR Docket No. 70877-703.601heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-Cealkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHC1-C3alkyl, -N(C1-C3alkyl)2, C1-C3alkyl, C1-C3alkoxy, C1-C3haloalkyl, C1-C3haloalkoxy, C1-C3hydroxyalkyl, C1-C3aminoalkyl, C1-C3heteroalkyl, or C3-C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Gaminoalk l. Ci-Csheteroalkyl, G-C’i cycloalk l. 4-15 membered heterocycloalkyl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
[0140] In some embodiments, U is C(H)-halogen, C(H)-0H, C(halogen)2, or C(OH)2. In some embodiments, each halogen is independently F, Cl, Br, or I. In some embodiments, halogen is F. In some embodiments, halogen is Cl. In some embodiments, halogen is Br. In some embodiments, halogen is I. In some embodiments, U is C(H)-C1.
[0141] In some embodiments, the compound of Formula (lib), U is N, CR5, C(R5)2,or -S-. In some embodiments, the compound of Formula (lib), U is N. In some embodiments, the compound of Formula (lib), U is CR5. In some embodiments, the compound of Formula (lib), U is NH. In some embodiments, the compound of Formula (lib), U is NR5. In some embodiments, the compound of Formula (lib), U is C(R5)2. In some embodiments, the compound of Formula (lib), U is CR5. In some embodiments, the compound of Formula (lib), U is CH2. In some embodiments, the compound of Formula (lib), U is CHR5. In some embodiments, the compound of Formula (lib), U is -S-. In some embodiments, the compound of Formula (lib), U is -O-.
[0142] In some embodiments, the compound of Formula (II) is of Formula (lie):WSGR Docket No. 70877-703.601
[0143] In some embodiments of a compound of Formula (II) or (Ila)-(IIc), Gi is N, NRN1, CRG1, or C(RG1)2. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), Gi is N. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), Gi is NRN1. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), Gi is CRG1. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), Gi is C(RG1)2. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), Gi is Nor CRG1.
[0144] In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is N, NRN2, CRG2, or C(RG2)2. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is N. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is NRN2. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is CRG2. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is C(RG2)2. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is N or CRG2.
[0145] In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is N, NRN3, CRG3, or C(RG3)2. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is CRG3or N. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is N. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is NRN3. In some embodiments of a compound of Formula (II) or (Ila)- (IIc), G2is CRG3. In some embodiments of a compound of Formula (II) or (Ila)-(IIc), G2is C(RG3)2. In some embodiments of a compound of Formula (II) or (Ila[0146...
Claims
WSGR Docket No. 70877-703.601CLAIMSWHAT IS CLAIMED IS:
1. A compound of Formula (I), or a pharmaceutically acceptable salt, or stereoisomer thereof:Formula (I),wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, - NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci- Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2- Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, C -C’i aryl. or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG2or RG3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RG1is hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, - NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C, -Ci aryl, 5- 15 membered heteroaryl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F;or two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, whereinWSGR Docket No. 70877-703.601the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; orone of RN1, RN2, and RN3and one of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, C2-C4alkenyl, C2-C4alkynyl, Ci-Csheteroalkyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or one R2is taken together with a substituent of L1with the intervening atoms to form C-C’i ar l. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- - NRcC(=O)O- -NRcC(=O)S- -NRcC(=S)O- -C(=O)NRC- -NRcC(=O)NRc- -NRcC(=S)NRc- - C(=S)NRC- -S(=O)2NRa-, -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, C1-C6alkylene, C1-C6heteroalkylene, C2-C6alkenylene, C2-C6alkynylene, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, -WSGR Docket No. 70877-703.601C(=O)NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C6-C15aryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;X is N or C;Y is N or C;V is N, C, or CRV;W is N, NRWN, C, CRW, C(RW)2, -S-, or -O-;RVis hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci-C6hydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;U is N, NR1". CRU, C(RU)2, -S-, or -O-;each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Ruare taken together to form an oxo, thioxo, =NH, or =N- Ci-C3alkyl;RUNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl,WSGR Docket No. 70877-703.601heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Z1is CRZ1or N;RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), - N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, - C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, - C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci- C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci- C3aminoalkyl, Ci-C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C,-C’i aryl. C3-Ci5cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ1is taken together with RWor RWNwith the intervening atoms to form Ring D;Z2is CRZ2or N;RZ2is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Z3is CRZ3or N;RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ3is taken together with one R3and the intervening atoms to form Ring E;Z4is CRZ4or N;RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -WSGR Docket No. 70877-703.601C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ4is taken together with RUor RUNwith the intervening atoms to form Ring C;Ring B is 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SFs, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, - S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15aryl, 5-15 membered heteroaryl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7 or 8;Ring C is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more Rc;Ring D is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RD;Ring E is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RE;Ring F is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RF;provided that (i) at least one of Ring C, Ring D, Ring E and Ring F is present, or that two of RG1, RG2and RG3on adjacent atoms are taken together with the atoms to which they are attached to form a C6-C15aryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, and (ii) Ring C and Ring D are not both present;each of Rc, RD, RE, and RFis independently -halogen, -CN, -OH, -ORa, -SFs, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, - OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-WSGR Docket No. 70877-703.601Ciscycloalkyl, Ce-Cisaryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two RC, two RD, and two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl;each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci- C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci- C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-C.alkyl. Ci-Csalkoxy, Ci-Cshaloalkyl, Ci- Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, heterocycloalkyl, or C3- C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2C1-C3alkyl, -S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)2N(C1-C3alkyl)2, -S(=O)(=NC1-C3alkyl)(C1-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, C,-Ci aryl, 5-15 membered heteroaryl, C\-Ci cycloalkyl. 4-15 membered heterocycloalkyl, (Ci-C.alkyl)- (Cs-Ciscycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two Ron the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
2. The compound of claim 1, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein V is CRV3. The compound of claim 1 or 2, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein V is C-OH.WSGR Docket No. 70877-703.6014. A compound of Formula (I), or a pharmaceutically acceptable salt, or stereoisomer thereof:Formula (I),wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, - NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci- Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2- Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, C, -C’i aryl. or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG2or RG3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RG1is hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, - NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C-CA aryl, 5- 15 membered heteroaryl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two RG1are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl; or RG1is taken together with a substituent of L1with the intervening atoms to form Ring F;or two of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; orWSGR Docket No. 70877-703.601one of RN1, RN2, and RN3and one of RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -S(=O)2NHCi-C3alkyl, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, C2-C4alkenyl, C2-C4alkynyl, Ci-Csheteroalkyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or one R2is taken together with a substituent of L1with the intervening atoms to form C-C’i ar l. Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O- - NRCC(=O)O- -NRCC(=O)S- -NRCC(=S)O- -C(=O)NRC- -NRCC(=O)NRC- -NRCC(=S)NRC- - C(=S)NRC- -S(=O)2NRa-, -S(=O)2-, -S(=O)(=NRb)-, -N=S(=O)(Ra)-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, C1-C6alkylene, C1-C6heteroalkylene, C2-C6alkenylene, C2-C6alkynylene, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 memberedWSGR Docket No. 70877-703.601heterocycloalkyl, C6-C15aryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;X is N or C;Y is N or C;V is N, C, or CRV;W is N, NRWN, C, CRW, C(RW)2, -S-, or -O-;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;U is N, NR1". CRU, C(RU)2, -S-, or -O-;each Ruis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Ruare taken together to form an oxo, thioxo, =NH, or =N- Ci-C3alkyl;RUNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C6-C15 aryl, 5-15 membered heteroaryl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Z1is CRZ1or N;RZ1is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), - N=S(=O)(Ci-C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, - C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, - C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-WSGR Docket No. 70877-703.601C3alkyl)3, Ci-Csalkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci- Csaminoalkyl, Ci-C3heteroalkyl, C -C3alkcnyl. CS-C’salkynyl. C,-C’i aryl. Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ1is taken together with RWor RWNwith the intervening atoms to form Ring D;Z2 is CRZ2or N;RZ2is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Z3is CRZ3or N;RZ3is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NCi-C3alkyl-C(=O)Ci-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ3is taken together with one R3and the intervening atoms to form Ring E;Z4 is CRZ4or N;RZ4is hydrogen, halogen, -CN, -OH, -SH, -SF5, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, - S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -N=S(=O)(Ci- C3alkyl)2, -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C2-C3alkenyl, C2-C3alkynyl, C6-C15aryl, C3-C15cycloalkyl, 4-15 membered heterocycloalkyl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or RZ4is taken together with RUor RUNwith the intervening atoms to form Ring C;Ring B is 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl;WSGR Docket No. 70877-703.601each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, - S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C,-Ci aryl, 5-15 membered heteroaryl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7 or 8;Ring C is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more Rc;Ring D is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RD;Ring E is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RE;Ring F is absent, C6-C15aryl, C5-C15cycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more RF;provided that (i) at least one of Ring C, Ring D, Ring E and Ring F is present, or that two of RG1, RG2and RG3on adjacent atoms are taken together with the atoms to which they are attached to form a C6-C15aryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, and (ii) Ring C and Ring D are not both present;each of Rc, RD, RE, and RFis independently -halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, - S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, - OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C15cycloalkyl, C6-C15aryl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocycloalkyl are optionally substituted with one or more R; or two RC, two RD, and two REon the same atom are taken together to form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl;each Rais independently C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-WSGR Docket No. 70877-703.601C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-Csalkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci- Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, heterocycloalkyl, or C3- C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2C1-C3alkyl, -S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)2N(C1-C3alkyl)2, -S(=O)(=NC1-C3alkyl)(C1-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci- Csheteroalkyl, Ce-Cis aryl, 5-15 membered heteroaryl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
5. The compound of any one of claims 1 to 4, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring E is present.
6. The compound of any one of claims 1 to 5, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is of Formula (la):Formula (la).WSGR Docket No. 70877-703.6017. The compound of any one of claims 1 to 4, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring C is present.
8. The compound of claim 7, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is of Formula (lb):Formula (lb).
9. The compound of any one of claims 1 to 4, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring D is present.
10. The compound of claim 9, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is of Formula (Ic):Formula (Ic).
11. The compound of any one of claims 1 to 4, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring F is present.
12. The compound of claim 11, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is of Formula (Id):Formula (Id).
13. The compound of any one of claims 1 to 4, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring E and Ring F are present.
14. The compound of claim 13, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is of Formula (le):WSGR Docket No. 70877-703.601Formula (le).
15. The compound of any one of claims 1 to 14, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Gi is CRG1or N.
16. The compound of any one of claims 1 to 15, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein G2 is CRG2.
17. The compound of any one of claims 1 to 16, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein G3 is CRG3.
18. The compound of any one of claims 1 to 16, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein G3 is N.
19. The compound of any one of claims 1 to 18, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RG1is hydrogen, halogen, -CN, -OH, -ORa, -SF5, -NRcRd, Ci-Cealkyl, or Ci- Cehaloalkyl, wherein the alkyl is optionally substituted with one or more R.
20. The compound of any one of claims 1 to 18, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RG1is taken together with a substituent of L1and the intervening atoms to form Ring F.
21. The compound of any one of claims 1 to 20, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RG2is halogen, -CN, -OH, -ORa, -SF5, -NRcRd, Ci-Cealkyl, Ci-Cehaloalkyl, or C3- Ciscycloalkyl, wherein the alkyl or cycloalkyl is optionally substituted with one or more R.
22. The compound of any one of claims 1 to 21, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RG2is Ci-Cehaloalkyl.
23. The compound of any one of claims 1 to 21, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RG2is -CF3 or -CHF2.
24. The compound of any one of claims 1 to 20, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RG2is 4-15 membered heterocycloalkyl optionally substituted with one or more R.
25. The compound of any one of claims 1 to 24, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RG3is hydrogen, halogen, -CN, -OH, -ORa, -SF5, -NRcRd, Ci-Cealkyl, or Ci- Cehaloalkyl, wherein the alkyl is optionally substituted with one or more R.
26. The compound of any one of claims 1 to 25, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RG3is hydrogen.
27. The compound of any one of claims 1 to 20, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 memberedWSGR Docket No. 70877-703.601heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R.
28. The compound of any one of claims 1 to 27, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L1is absent.
29. The compound of any one of claims 1 to 27, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L1is -O-, -NRC-, -C(=O)O- -NRCC(=O)O- -C(=O)NRC- -NRCC(=O)NRC- Ci- Cealkylene, Ci-Ceheteroalkylene, C2-Cealkenylene, or C2-Cealkynylene, wherein the alkylene, heteroalkylene, alkenylene, or alkynylene is optionally substituted with one or more R.
30. The compound of any one of claims 1 to 27, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L1is -C(=O)NRC-.
31. The compound of any one of claims 29 to 30, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L1is -NRC-, -NRCC(=O)O- -C(=O)NRC- -NRCC(=O)NRC- Ci-C6alkylene, Ci- Ceheteroalkylene, C2-Cealkenylene, or C2-Cealkynylene, wherein the alkylene, heteroalkylene, alkenylene, or alkynylene is optionally substituted with one or more R, and wherein one of the R or Rcis taken together with RG1and the intervening atoms to form Ring F.
32. The compound of any one of claims 29 to 30, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L1is -C(=O)NRC- and Rcand RG1are taken together with the intervening atoms to form Ring F.
33. The compound of any one of claims 29 to 32, or a pharmaceutically acceptable salt, or stereoisomer ms to34. The compound of any one of claims 1 to 33, or a pharmaceutically acceptable salt, or stereoisomerWSGR Docket No. 70877-703.60135. The compound of any one of claims 1 to 34, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring A is Ce-Cioaryl.
36. The compound of any one of claims 1 to 34, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring A is C, aryl.
37. The compound of any one of claims 1 to 36, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein n is 0, 1, or 2.
38. The compound of any one of claims 1 to 37, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, - S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl,-NRcRd, or -P(=O)(Ci-C3alkyl)2.
39. The compound of any one of claims 1 to 37, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein each R2is independently halogen.
40. The compound of any one of claims 1 to 39, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L2is absent, -NRC-, -C(=O)O- -NRcC(=O)O- -C(=O)NRC- -C(Re)=N-, or - NRCC(=O)NRC-.
41. The compound of any one of claims 1 to 39, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L2is absent or-C(=O)NRc-.
42. The compound of any one of claims 1 to 39, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L2is -C(=O)NRC-.
43. The compound of any one of claims 1 to 39, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L2is -C(=O)O-.
44. The compound of any one of claims 1 to 39, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein L2is -C(Re)=N-.
45. The compound of any one of claims 1 to 44, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein R22is hydrogen, halogen, -CN, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, - OC(=O)NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, Cs-Ciocycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cioaryl, or 5-15 membered heteroaryl; wherein the cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a.WSGR Docket No. 70877-703.60146. The compound of any one of claims 1 to 44, or a pharmaceutically acceptable salt, or stereoisomerthereof, wherein47. The compound of any one of claims 1 to 44, or a pharmaceutically acceptable salt, or stereoisomer48. The compound of any one of claims 1 to 47, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein each R22ais independently halogen, -CN, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, - OC(=O)NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -C(=O)Ra, -C(=O)ORb, - C(=O)NRcRd, Ci-Cealkyl, Ci-Cealkoxy, or Cs-Ciscycloalkyl, wherein each alkyl or cycloalkyl is independently optionally substituted with one or more R, or two R22aon the same atom form an oxo.
49. The compound of any one of claims 1 to 48, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein X is N.
50. The compound of any one of claims 1 to 48, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein X is C.
51. The compound of any one of claims 1 to 50, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Y is C.
52. The compound of any one of claims 1 to 51, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein W is NRWN, CRW, or -S-.
53. The compound of any one of claims 1 to 51, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein W is NRWN.
54. The compound of any one of claims 1 to 51, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein W is -S-.
55. The compound of any one of claims 1 to 51, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein W is -O-.
56. The compound of any one of claims 1 to 51, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein W is CRW57. The compound of any one of claims 1 to 56, wherein Rwis hydrogen, Ci-Cealkyl, or C3- Ciscycloalkyl, wherein the alkyl or cycloalkyl is optionally substituted with two or more R.WSGR Docket No. 70877-703.60158. The compound of any one of claims 1 to 56, wherein Rwis halogen.
59. The compound of any one of claims 1 to 56, wherein Rwis ethyl.
60. The compound of any one of claims 1 to 53, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein R'™ is Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Ceheteroalkyl, C3-C10 cycloalkyl, or 4-10 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R.
61. The compound of any one of claims 1 to 53, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein R'™ is Ci-Cealkyl or Ci-Ceheteroalkyl, wherein the alkyl or heteroalkyl is optionally substituted with one or more R.
62. The compound of any one of claims 1 to 53, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein R'™ is Ci-Cealkyl.
63. The compound of any one of claims 1 to 53, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein R'™ is C3-C10 cycloalkyl optionally substituted with one or more R.
64. The compound of any one of claims 1 to 53, or a pharmaceutically acceptable salt, or stereoisomerthereof, wherein R'™ is ethyl,65. The compound of any one of claims 1 to 64, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein V is C.
66. The compound of any one of claims 1 to 65, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein U is N, NR' \ -S-, or CRT67. The compound of any one of claims 1 to 65, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein U is CRU.
68. The compound of any one of claims 1 to 65, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein U is N.
69. The compound of any one of claims 1 to 65, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein U is C(RU)2.
70. The compound of any one of claims 1 to 65, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein U is -S-.
71. The compound of any one of claims 1 to 65, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein U is NRl -\72. The compound of any one of claims 1 to 71, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein R™ is Ci-Cealkyl or C3-C15 cycloalkyl, wherein the alkyl or cycloalkyl is optionally substituted with one or more R.
73. The compound of any one of claims 1 to 69, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein each Ruis independently hydrogen, halogen, Ci-Cealkyl, or C3-C15 cycloalkyl, wherein the alkyl or cycloalkyl is optionally substituted with one or more R.
74. The compound of any one of claims 1 to 69, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein each Ruis independently hydrogen, F, or ethyl.WSGR Docket No. 70877-703.60175. The compound of any one of claims 1 to 74, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Zi is CRZ1.
76. The compound of any one of claims 1 to 75, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ1is hydrogen.
77. The compound of any one of claims 1 to 75, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ1is halogen.
78. The compound of any one of claims 1 to 75, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ1is taken together with Rwor RWNwith the intervening atoms to form Ring D.
79. The compound of any one of claims 1 to 78, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Z2 is CRZ2.
80. The compound of any one of claims 1 to 79, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ2is hydrogen.
81. The compound of any one of claims 1 to 80, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Z3 is CRZ3.
82. The compound of any one of claims 1 to 81, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ3is hydrogen.
83. The compound of any one of claims 1 to 81, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ3is taken together with one R3with the intervening atoms to form Ring E.
84. The compound of any one of claims 1 to 81, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ3is taken together with one R3with the intervening atoms to form Ring E,85. The compound of any one of claims 1 to 81, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ3is taken together with one R3with the intervening atoms to form Ring E,86. The compound of any one of claims 1 to 85, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Z4 is CRZ4.WSGR Docket No. 70877-703.60187. The compound of any one of claims 1 to 86, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ4is hydrogen.
88. The compound of any one of claims 1 to 86, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein RZ4is taken together with RUor RUNwith the intervening atoms to form Ring C.
89. The compound of any one of claims 1 to 85, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Z4 is N.
90. The compound of any one of claims 1 to 89, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring F is 5-15 membered heterocycloalkyl optionally substituted with one or more RF.
91. The compound of any one of claims 1 to 89, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring F is 6-8 membered heterocycloalkyl optionally substituted with one or more RF.
92. The compound of any one of claims 1 to 89, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring F is monocyclic or bicyclic.
93. The compound of any one of claims 1 to 92, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring D is 5-15 membered heterocycloalkyl optionally substituted with one or moreRD.
94. The compound of any one of claims 1 to 93, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring E is 5-15 membered heterocycloalkyl optionally substituted with one or moreRE.
95. The compound of any one of claims 1 to 93, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring E is 7-membered heterocycloalkyl optionally substituted with one or more RE.
96. The compound of any one of claims 1 to 95, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring E is monocyclic.
97. The compound of any one of claims 1 to 95, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring E is bicyclic.
98. The compound of any one of claims 1 to 97, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein REis methyl.
99. The compound of any one of claims 1 to 98, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring C is 5-15 membered heterocycloalkyl optionally substituted with one or more Rc.
100. The compound of any one of claims 1 to 99, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein two Rc, two RD, and two REon the same atom are taken together to form an oxo.
101. The compound of any one of claims 1 to 100, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring B is 5-10 membered heteroaryl.
102. The compound of any one of claims 1 to 101, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein each R3is independently halogen, -CN, -OH, -ORa, -NRcRd, -C(=O)Ra,WSGR Docket No. 70877-703.601-C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, or two R3on the same atom form an oxo.
103. The compound of any one of claims 1 to 102, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein each R3is independently Ci-Cealkyl or two R3on the same atom form an oxo.
104. The compound of any one of claims 1 to 102, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein R3is methyl.
105. The compound of any one of claims 1 to 104, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring B is a 5 -membered heteroaryl.
106. The compound of any one of claims 1 to 104, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein Ring B is a triazole.
107. The compound of any one of claims 1 to 104, or a pharmaceutically acceptable salt, oroHNI.Nstereoisomer thereof, wherein Ring B is or H108. The compound of any one of claims 1 to 104, or a pharmaceutically acceptable salt, or110. The compound of any one of claims 1 to 109, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein p is 1, 2, or 3.
111. The compound of any one of claims 1 to 110, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is selected from Table 1.
112. A compound of Formula (II), or a pharmaceutically acceptable salt, or stereoisomer thereof:Formula (II),WSGR Docket No. 70877-703.601wherein:G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG1, RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, - S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci- Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 4-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a Ce- saryl, C5- Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or two RG' RG2or RG3, on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci- Galkyl;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, C1-C3aminoalkyl, C2-C4alkenyl, C2-C4alkynyl, C1-C3heteroalkyl, C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is an integer from 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O-, -NRCC(=O)O- -NRCC(=O)S- -NRCC(=S)O- -S(=O)2-,-S(=O)(=NRb)-, -N=S(=O)(Ra)-, -C(=O)NRC-, -NRcC(=O)NRc- -NRcC(=S)NRc- -C(=S)NRC- -S(=O)2NRa-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-C6alkylene, G- Ceheteroalkylene, G-Galkenylene, G-Galkynylene, Ce-Cioaryl, G-Gscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;WSGR Docket No. 70877-703.601R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciocycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;each ' ' is independently a single bond or a double bond;Ring G is a 5 membered heterocycloalkyl or 5-6 membered heteroaryl comprising ring members Y, X, W, and V;X and Y are each independently C or N;V is CH, C, orN;W is C, CRW, C(RW)2, N, NRWN, -S-, or -O-;wherein, when (i) W is NRWNand ring G is a pyrrole, or (ii) W is NRWN, X is C, Y is C, and ring G is an imidazole, then the 6-membered ring comprising Gi, G2, Gs, X and Y is a pyridone;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SH, -SRa, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Ci -C.alky 1-C - Cecycloalkyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;each R5is independently Ci-Cealkyl. Ci-Csalkoxy, Ci-Cehaloalkyl. Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, C 1 -Ceaminoalkyl. or C 1 -Cehctcroalkyl: or two R5are taken together to form an oxo;WSGR Docket No. 70877-703.601q is 0, 1, or 2;L3is C1-C6alkynylene, C6-C10aryl, C3-C10heteroaryl, C4-C10heterocycloalkyl, or C3-C10cycloalkyl, wherein the aryl, heteroaryl, heterocycloalkyl, or cycloalkyl is optionally substituted with one or more R;Ring B is 5-15 membered heteroaryl or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, - C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, - S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6hydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is an integer 0, 1, 2, 3, 4, 5, 6, 7 or 8;each Rais independently C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci- Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci-C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-C6alkyl, Ci-Csalkoxy, Ci-Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, or C3-C6cycloalkyl, wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci- C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-WSGR Docket No. 70877-703.601Csalkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, - C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, - NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci- C3alkoxy, Ci-C3haloalkyl, Ci-C3haloalkoxy, Ci-C3hydroxyalkyl, Ci-C3aminoalkyl, Ci- C3heteroalkyl, C3-Ci5cycloalkyl, 4-15 membered heterocycloalkyl, C-Ci aryl, 5-15 membered heteroaryl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
113. The compound of claim 112, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is of Formula (Ila):
114. A compound, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is of Formula (lib):wherein,G1is N, NRN1, CRG1, or C(RG1)2;G2is N, NRN2, CRG2, or C(RG2)2;G3is N, NRN3, CRG3, or C(RG3)2;each of RG1, RG2and RG3is independently hydrogen, halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, - S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRbS(=O)2Ra, -SRa(=O)(=NRb), -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ra)2, Ci- Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-Ci5cycloalkyl, 4-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl is optionally substituted with one or more R; or two RG1, RG2and RG3on neighboring atoms are taken together with the atoms to which they are attached to form a C,-Ci aryl. C\- Ciscycloalkyl, 5-15 membered heteroaryl, or 5-15 membered heterocycloalkyl, wherein the aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R; or twoWSGR Docket No. 70877-703.601RG1, RG2or RG3, on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-Csalkyl;each of RN1, RN2, and RN3is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;Ring A is C6-C15aryl, C3-C15cycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl; each R2is independently halogen, -CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, - S(=O)2NH2, -S(=O)2NHC1-C3alkyl, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci- Cshaloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, C2-C4alkenyl, C2-C4alkynyl, Ci-Csheteroalkyl, Ce-Cisaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl is optionally substituted with one or more R;n is an integer from 0, 1, 2, 3, 4, or 5;R6is absent or L2-R22;each of L1and L2is independently absent, -O-, -S-, -NRC-, -NRCSO2-, -C(Re)=N-, -C(=O)-, -C(=O)O-, -NRCC(=O)O- -NRCC(=O)S- -NRCC(=S)O- -S(=O)2-,-S(=O)(=NRb)-, -N=S(=O)(Ra)-, -C(=O)NRC-, -NRCC(=O)NRC- -NRCC(=S)NRC- -C(=S)NRC- -S(=O)2NRa-, -OP(=O)(ORa)NRb-, - OP(=O)(NRaRb)O-, -NRcC(=NRc)-, -P(=O)(Ra)-, -P(=O)(Ra)CH2-, Ci-C6alkylene, Ci- Ceheteroalkylene, C2-Cealkenylene, C2-Cealkynylene, Ce-Cioaryl, Cs-Ciscycloalkyl, 5-15 membered heteroaryl, or 4-15 membered heterocycloalkyl, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, cycloalkyl, aryl, heteroaryl or heterocycloalkyl is optionally substituted with one or more R;R22is hydrogen, halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, - NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciocycloalkyl, 5-15 membered heterocycloalkyl, Ce-Cisaryl, or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R22a;each R22ais independently halogen, -CN, -NO2, -OH, -ORa, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, - SH, -SF5, -SRa, -S(=O)Ra, -S(=O)2Ra, -S(=O)2NRcRd, -NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -S(=O)(=NRb)(Ra), - N=S(=O)(Ra)2, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cealkoxy, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, Cs-Ciscycloalkyl, 5-15 membered heterocycloalkyl, C,-C’i aryl. or 5-15 membered heteroaryl; wherein each alkyl, heteroalkyl,WSGR Docket No. 70877-703.601alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R, or two R22aon the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;a single bond or a double bond;Ring G is a 5 membered heterocycloalkyl or 5-6 membered heteroaryl comprising ring members Y, X, W, and V;X and Y are each independently C or N;U is N, NR5, NH, CR5, CH, CH2, CHR5, C(R5)2, -S-, or -O-;V is CH, C, orN;W is C, CRW, C(RW)2, N, NR" \ -S-, or -O-;wherein, when (i) W is NRWNand ring G is a pyrrole, or (ii) W is NRWN, X is C, Y is C, and ring G is an imidazole, then the 6-membered ring comprising G1, G2, G3, X and Y is a pyridone;each Rwis independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SH, -SRa, -NRcRd, -C(=O)Ra, - C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C6alkyl, Ci-C6haloalkyl, Ci-C6alkoxy, Ci- Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, C3-C15 cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R; or two Rware taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;RWNis -CN, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkyl-C3-C6cycloalkyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl is optionally substituted with one or more R;each R5is independently hydrogen, halogen, -CN, -NO2, -OH, -ORa, -SF5, -SH, -SRa, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRbC(=O)Ra, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci- Cdialoalkoxy. Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, or Ci-Csheteroalkyl; or two R5are taken together to form an oxo;q is 0, 1, or 2;L3is C1-C6alkynylene, C6-C10aryl, C3-C10heteroaryl, C4-C10heterocycloalkyl, or C3-C10cycloalkyl, wherein the aryl, heteroaryl, heterocycloalkyl, or cycloalkyl is optionally substituted with one or more R;Ring B is 5-15 membered heteroaryl or 4-15 membered heterocycloalkyl;each R3is independently halogen, -CN, -OH, -ORa, -SF5, -SH, -SRa, -S(=O)Ra, -S(=O)2Ra, -NRcRd, -C(=O)Ra, -C(=O)ORb, -C(=O)NRcRd, -NRcC(=O)Ra, -OC(=O)Ra, -OC(=O)ORb, -OC(=O)NRcRd, -S(=O)2NRcRd, -NRbC(=O)NRcRd, -NRbC(=O)Ra, -NRbC(=O)ORb, -NRbS(=O)2Ra, -S(=O)(=NRb)(Ra), -N=S(=O)(Ra)2, -P(=O)(Ra)2, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C15cycloalkyl, or 4-15 membered heterocycloalkyl, wherein the alkyl, heteroalkyl, alkenyl, alkynyl, cycloalkyl andWSGR Docket No. 70877-703.601heterocycloalkyl are optionally substituted with one or more R; or two R3on the same atom are taken together to form an oxo, thioxo, =NH, or =N-Ci-C3alkyl;p is 0, 1, 2, 3, 4, 5, 6, 7, or 8;each Rais independently Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci- Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci- C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R; each Rbis independently hydrogen, Ci-Cealkyl, Ci-Cehaloalkyl, Ci-Cehydroxyalkyl, Ci-Ceaminoalkyl, Ci-Ceheteroalkyl, C2-Cealkenyl, C2-Cealkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, Ci- C6alkylene(cycloalkyl), Ci-C6alkylene(heterocycloalkyl), Ci-Cealkylene(aryl), or Ci- C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;Rcand Rdare each independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene(cycloalkyl), C1-C6alkylene(heterocycloalkyl), C1-C6alkylene(aryl), or C1-C6alkylene(heteroaryl), wherein each alkyl, heteroalkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more R;or Rcand Rdare taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;Reis -NH2, -NRcRd, -NHCi-Csalkyl, -N(Ci-C3alkyl)2, Ci-Cealkyl. Ci-Csalkoxy, Ci-Cshaloalkyl, Ci- Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-Csaminoalkyl, Ci-Csheteroalkyl, or Cs-C. cycloalkyl. wherein each alkyl, heteroalkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more R; andeach R is independently halogen, -CN, (Ci-Cealkyl)CN, -OH, -SF5, -SH, -S(=O)Ci-C3alkyl, -S(=O)2Ci-C3alkyl, -S(=O)2NH2, -S(=O)2NHCi-C3alkyl, -S(=O)2N(Ci-C3alkyl)2, -S(=O)(=NCi-C3alkyl)(Ci-C3alkyl), -NH2, -NHCi-C3alkyl, -N(Ci-C3alkyl)2, -N=S(=O)(Ci-C3alkyl)2, -C(=O)Ci-C3alkyl, -C(=O)OH, -C(=O)OCi-C3alkyl, -C(=O)NH2, -C(=O)NHCi-C3alkyl, -C(=O)N(Ci-C3alkyl)2, -NHC(=O)Ci-C3alkyl, -NC1-C3alkyl-C(=O)C1-C3alkyl, -P(=O)(Ci-C3alkyl)2, Ci-C3alkyl, Ci-C3alkoxy, Ci-C3haloalkyl, Ci-Cshaloalkoxy, Ci-Cshydroxyalkyl, Ci-C’sammoalkyl. Ci-Csheteroalkyl, C\-Ci cycloalkyl. 4-15 membered heterocycloalkyl, Ce-Cis aryl, 5-15 membered heteroaryl, (Ci-C3alkyl)-(C3-Ci5cycloalkyl), or (Ci-C3alkyl)-(4-15 membered heterocycloalkyl); or two R on the same atom form an oxo, thiooxo, =NH, or =N-Ci-C3alkyl.
115. The compound of claim 112, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is of Formula (lib):WSGR Docket No. 70877-703.601wherein,U is N, NR5, NH, CR5, CH, CH2, CHR5, C(R5)2, -S-, or -0-.
116. The compound of any one of claims 114 to 115, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is of Formula (lie):Formula (lie).
117. The compound of any one of claims 112 to 116, or a pharmaceutically acceptable salt, or stereoisomer thereof, wherein the compound is selected from Table 2.
118. A compound selected from Table 3, or a pharmaceutically acceptable salt or stereoisomer thereof.
119. A pharmaceutical composition comprising the compound of any one of claims 1 to 118, or a pharmaceutically acceptable salt, or stereoisomer thereof, and optionally a pharmaceutically acceptable excipient.
120. A method of modulating IL-4 or IL- 13 in a subject in need thereof, the method comprising administering to the subject an effective amount of the compound of any one of claims 1 to 118, or a pharmaceutically acceptable salt, or stereoisomer thereof, or the pharmaceutical composition of claim 119.
121. A method of treating a disease modulated by IL-4 or IL- 13 in a subject in need thereof, the method comprising administering to the subject an effective amount of the compound of any one of claims 1 to 118, or a pharmaceutically acceptable salt, or stereoisomer thereof, or the pharmaceutical composition of claim 119.
122. The method of claim 121, wherein the disease is an inflammatory disorder, an autoimmune condition, a fibrotic condition, or cancer.
123. The method of claim 122, wherein the inflammatory disorder is a T-helper type 2 mediated inflammatory disorder.
124. The method of claim 121 or 122, wherein the inflammatory disorder is atopic dermatitis (eczema), asthma (allergic or eosinophilic), allergic rhinitis, conjunctivitis, chronic spontaneousWSGR Docket No. 70877-703.601urticaria (CSU), prurigo nodularis, eosinophilic esophagitis, eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), hypereosinophilic syndrome, allergic bronchopulmonary aspergillosis, or IgE-mediated food allergies.
125. The method of claim 122, wherein the autoimmune or fibrotic condition is chronic obstructive pulmonary disease (COPD), bullous pemphigoid, Sjogren’s syndrome, Graves’ disease, systemic lupus erythematosus, atopic keratoconjunctivitis, inflammatory bowel disease (IBD), ulcerative colitis, Crohn’s disease, systemic sclerosis (scleroderma), idiopathic pulmonary fibrosis (IPF) and related interstitial lung diseases, liver fibrosis, steatohepatitis, Graft-Versus-Host Disease (GVHD) and Transplantation.
126. The method of claim 122, wherein the cancer is breast cancer, prostate cancer, gliomas, or head or neck squamous cell carcinoma (e.g., with STAT6 gain-of-function).
127. The method of any one of claims 121 to 126, wherein the compound or pharamecutical composition is administered with an additional therapeutic agent.
